<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28066177</article-id>
<article-id pub-id-type="pmc">5174119</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2016.00150</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Prenatal Valproate Exposure Differentially Affects Parvalbumin-Expressing Neurons and Related Circuits in the Cortex and Striatum of Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lauber</surname>
<given-names>Emanuel</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/379925/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Filice</surname>
<given-names>Federica</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/392956/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schwaller</surname>
<given-names>Beat</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/38834/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Anatomy, Department of Medicine, University of Fribourg</institution>
<country>Fribourg, Switzerland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <italic>Oliver Stork, Otto-von-Guericke University Magdeburg, Germany</italic></p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <italic>Anne Albrecht, Leibniz Institute for Neurobiology, Germany; Takanori Hashimoto, Kanazawa University, Japan</italic></p>
</fn>
<corresp id="fn001">*Correspondence: <italic>Beat Schwaller, <email xlink:type="simple">beat.schwaller@unifr.ch</email></italic></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>9</volume>
<elocation-id>150</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>9</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Lauber, Filice and Schwaller.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Lauber, Filice and Schwaller</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Autism spectrum disorders (ASD) comprise a number of heterogeneous neurodevelopmental diseases characterized by core behavioral symptoms in the domains of social interaction, language/communication and repetitive or stereotyped patterns of behavior. <italic>In utero</italic> exposure to valproic acid (VPA) has evolved as a highly recognized rodent ASD model due to the robust behavioral phenotype observed in the offspring and the proven construct-, face- and predictive validity of the model. The number of parvalbumin-immunoreactive (PV<sup>+</sup>) GABAergic interneurons has been consistently reported to be decreased in human ASD subjects and in ASD animal models. The presumed loss of this neuron subpopulation hereafter termed Pvalb neurons and/or PV deficits were proposed to result in an excitation/inhibition imbalance often observed in ASD. Importantly, loss of Pvalb neurons and decreased/absent PV protein levels have two fundamentally different consequences. Thus, Pvalb neurons were investigated in <italic>in utero</italic> VPA-exposed male (“VPA”) mice in the striatum, medial prefrontal cortex (mPFC) and somatosensory cortex (SSC), three ASD-associated brain regions. Unbiased stereology of PV<sup>+</sup> neurons and Vicia Villosa Agglutinin-positive (VVA<sup>+</sup>) perineuronal nets, which specifically enwrap Pvalb neurons, was carried out. Analyses of PV protein expression and mRNA levels for <italic>Pvalb, Gad67, Kcnc1, Kcnc2, Kcns3, Hcn1, Hcn2, and Hcn4</italic> were performed. We found a ∼15% reduction in the number of PV<sup>+</sup> cells and decreased <italic>Pvalb</italic> mRNA and PV protein levels in the striatum of VPA mice compared to controls, while the number of VVA<sup>+</sup> cells was unchanged, indicating that Pvalb neurons were affected at the level of the transcriptome. In selected cortical regions (mPFC, SSC) of VPA mice, no quantitative loss/decrease of PV<sup>+</sup> cells was observed. However, expression of <italic>Kcnc1</italic>, coding for the voltage-gated potassium channel K<sub>v</sub>3.1 specifically expressed in Pvalb neurons, was decreased by ∼40% in forebrain lysates of VPA mice. Moreover, hyperpolarization-activated cyclic nucleotide-gated channel (HCN) 1 expression was increased by ∼40% in the same samples from VPA mice. We conclude that VPA leads to alterations that are brain region- and gene-specific including <italic>Pvalb, Kcnc1</italic>, and <italic>Hcn1</italic> possibly linked to homeostatic mechanisms. Striatal PV down-regulation appears as a common feature in a subset of genetic (Shank3B-/-) and environmental ASD models.</p>
</abstract>
<kwd-group>
<kwd>ASD</kwd>
<kwd>VPA</kwd>
<kwd>parvalbumin</kwd>
<kwd>K<sub>v</sub>3</kwd>
<kwd>HCN</kwd>
<kwd>excitation/inhibition balance</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung<named-content content-type="fundref-id">10.13039/501100001711</named-content></funding-source>
<award-id rid="cn001">310030_155952/1</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="3"></table-count>
<equation-count count="1"></equation-count>
<ref-count count="101"></ref-count>
<page-count count="16"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Autism Spectrum Disorders (ASD) are a group of neurodevelopmental disorders that share core behavioral symptoms in the domains of social interaction, language/communication and repetitive, or stereotyped patterns of behavior (<xref ref-type="bibr" rid="B2">American Psychiatric Association, 2013</xref>). The etiology of ASD is still poorly understood; ASD is viewed as a multifactorial disease, caused by a combination of genetic, epigenetic, and environmental cues. The genetics of ASD are extremely heterogeneous with a large number (&gt;100) of identified risk genes, yet mutations in one of these risk genes occur sporadic and do not affect more than 1–2% of ASD cases (<xref ref-type="bibr" rid="B55">Kleijer et al., 2014</xref>; <xref ref-type="bibr" rid="B22">de la Torre-Ubieta et al., 2016</xref>). Environmental insults during embryonic development and early postnatal life are thus considered to play an important role in ASD pathophysiology.</p>
<p>Valproic acid (VPA; also known as valproate) is used in clinics for the treatment of epilepsy and psychiatric conditions such as bipolar disorders and acute mania (<xref ref-type="bibr" rid="B42">Haddad et al., 2009</xref>). Epidemiological studies in children have shown a positive correlation between <italic>in utero</italic> VPA exposure and the diagnosis of ASD (<xref ref-type="bibr" rid="B8">Bromley et al., 2013</xref>; <xref ref-type="bibr" rid="B19">Christensen et al., 2013</xref>). VPA monotherapy during pregnancy results in about seven-fold greater incidence of ASD or ASD key symptoms including language impairment, reduced attention, social deficits and restricted interests (<xref ref-type="bibr" rid="B93">Vinten et al., 2009</xref>). The effects of VPA are thought to be induced by a broad range of molecular mechanisms including: inhibition of histone deacetylation (HDAC) (<xref ref-type="bibr" rid="B77">Phiel et al., 2001</xref>; <xref ref-type="bibr" rid="B38">Gottfried et al., 2013</xref>), inositol depletion (<xref ref-type="bibr" rid="B26">Eickholt et al., 2005</xref>), increase in fetal oxidative stress (<xref ref-type="bibr" rid="B92">Verrotti et al., 2008</xref>), changes in gene expression (<xref ref-type="bibr" rid="B73">Ornoy, 2009</xref>) and induction of GABA synthesis (<xref ref-type="bibr" rid="B61">Loscher, 1999</xref>). VPA exposure during pregnancy has been extensively studied in rodents and has evolved as the well-established “VPA mouse or rat model” for the study of ASD. Behavioral phenotypes related to all human core symptoms of ASD including impaired social behavior, repetitive or stereotyped patterns of behavior and impaired communication exist in juvenile VPA rats and mice and persist into adulthood (reviewed in <xref ref-type="bibr" rid="B83">Roullet et al., 2013</xref>; <xref ref-type="bibr" rid="B28">Ergaz et al., 2016</xref>). The striking and robust ASD phenotype, together with the given construct validity, has made it attractive for further studying the pathophysiology of ASD.</p>
<p>Amongst other morpho-functional abnormalities, VPA mice or rats were reported to exhibit a loss of PV-immunoreactive (PV<sup>+</sup>) neurons in “PV-empty zones”, i.e., patchy zones devoid of PV immunoreactivity observed on sections of the neocortex (<xref ref-type="bibr" rid="B37">Gogolla et al., 2009</xref>); and in the colliculi superiors (<xref ref-type="bibr" rid="B24">Dendrinos et al., 2011</xref>). Pvalb neuronal loss and/or decreased PV expression has also been observed in post-mortem brains of human ASD patients (<xref ref-type="bibr" rid="B101">Zikopoulos and Barbas, 2013</xref>; <xref ref-type="bibr" rid="B89">Stoner et al., 2014</xref>; <xref ref-type="bibr" rid="B44">Hashemi et al., 2016</xref>) and various ASD mouse models (see Table 1 in <xref ref-type="bibr" rid="B98">Wohr et al., 2015</xref>). PV is a calcium-binding protein expressed in specific neurons in the brain (<xref ref-type="bibr" rid="B11">Celio, 1990</xref>) and for decades, PV has been used as a reliable marker for a subset of GABAergic inhibitory neurons in the CNS (<xref ref-type="bibr" rid="B12">Celio and Heizmann, 1981</xref>). In these neurons, PV serves as a slow-onset Ca<sup>2+</sup> buffer modulating several Ca<sup>2+</sup>-dependent processes. PV<sup>-/-</sup> mice show alterations in synaptic transmission including short-term plasticity, kinetics of delayed transmitter release, precision of spike timing, excitability, as well as other deviations (for review see <xref ref-type="bibr" rid="B86">Schwaller, 2012</xref>). Moreover, Pvalb neurons in the cortex are essential players in generating gamma band oscillations (<xref ref-type="bibr" rid="B4">Bartos et al., 2002</xref>; <xref ref-type="bibr" rid="B9">Buzsaki and Wang, 2012</xref>). Selectively reducing Pvalb neuronal activity strongly attenuates gamma oscillations, a phenomenon often observed in ASD and schizophrenia patients during cognitive tasks (<xref ref-type="bibr" rid="B17">Cho et al., 2006</xref>; <xref ref-type="bibr" rid="B88">Sohal et al., 2009</xref>). Although <italic>Pvalb</italic> has never been described as an ASD risk gene, PV-deficient (PV<sup>+/-</sup> and PV<sup>-/-</sup>) mice show a striking ASD phenotype in all core domains (<xref ref-type="bibr" rid="B98">Wohr et al., 2015</xref>). Moreover, structural MRI revealed ASD-associated neuroanatomical changes such as transient cortical hypertrophy and cerebellar hypoplasia in PV<sup>+/-</sup> and PV<sup>-/-</sup> mice (<xref ref-type="bibr" rid="B98">Wohr et al., 2015</xref>). Importantly, Pvalb neurons in PV<sup>+/-</sup> and PV<sup>-/-</sup> mice (and also in the validated ASD models Shank1<sup>-/-</sup> and Shank3B<sup>-/-</sup> mice) are not lost, a conclusion often drawn too early when Pvalb neurons are quantified solely using PV as marker. Rather, PV expression levels might be low or absent, thus falling under detection threshold, while the Pvalb neuron number is unchanged. The latter was shown by stereological analysis of perineuronal nets (PNNs), which represent an alternative marker for Pvalb neurons or using PV-EGFP mice (<xref ref-type="bibr" rid="B68">Meyer et al., 2002</xref>) expressing EGFP in Pvalb neurons independent of endogenous PV expression levels (<xref ref-type="bibr" rid="B33">Filice et al., 2016</xref>). Here, we investigated whether Pvalb neuron numbers were altered and/or if PV expression was down-regulated in three ASD-linked brain regions, namely the mPFC, SSC and striatum of VPA male mice. Since these regions receive a vast number of sensory inputs, they are crucial for multisensory integration, executive function, language, social cognition, motivational state and regulation of emotional behavior. Alterations in the structure and function of the mPFC (<xref ref-type="bibr" rid="B67">Martinez-Sanchis, 2014</xref>), SSC (<xref ref-type="bibr" rid="B65">Markram and Markram, 2010</xref>; <xref ref-type="bibr" rid="B54">Khan et al., 2016</xref>) and striatum (<xref ref-type="bibr" rid="B34">Fuccillo, 2016</xref>) have been consistently reported in ASD. We found PV expression levels to be decreased in the striatum, but not in forebrain lysates comprising the two selected ASD-linked cortical regions. In all 3 brain regions, the number of Pvalb neurons was unchanged between VPA and control mice, strongly arguing against a loss of Pvalb neurons. VPA mice exhibited alterations in the expression of potassium channels; mRNA and protein levels of K<sub>v</sub>3.1, selectively expressed in Pvalb neurons, was decreased, whereas expression of hyperpolarization-activated cyclic nucleotide gated-channel (HCN) 1 was up-regulated in forebrain lysates. HCN channel-mediated I<sub>h</sub> currents are impaired in Shank3<sup>-/-</sup> mice (<xref ref-type="bibr" rid="B100">Yi et al., 2016</xref>), which exhibit striatal PV downregulation similar to VPA mice as described in this report. These changes are likely to affect the E/I balance that is often altered in the brain of ASD subjects (<xref ref-type="bibr" rid="B91">Uhlhaas and Singer, 2007</xref>).</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Animals</title>
<p>All mice were group-housed at the University of Fribourg, Switzerland in temperature-controlled animal facilities (24°C, 12:12 h light/dark cycle), fed <italic>ad libitum</italic> with free access to water. C57Bl/6J mice were mated overnight until a vaginal plug was detected in the morning. The day of sperm plug detection was defined as gestational day 0 (GD0). At GD12, 600 mg/kg valproic acid sodium salt (VPA; P4543 Sigma–Aldrich, Buchs, Switzerland) diluted in 0.9% NaCl was administered by oral gavage. Control animals were administered with 0.9% NaCl. Pups were not weaned; brains were taken after cerebral dislocation at postnatal day (PND) 25 ± 1. Only male mice were used in this study. All experiments were performed with permission of the local animal care committee (Canton of Fribourg, Switzerland) and according to the present Swiss law and the European Communities Council Directive of 24 November 1986 (86/609/EEC).</p>
</sec>
<sec>
<title>Tissue Preparation and Immunohistochemistry</title>
<p>Mice at PND25 were anesthetized (Esconarkon, Streuli Pharma AG, Uznach, Switzerland) and perfused with 0.9% saline solution followed by 4% PFA. Brains were removed and post-fixed for 24 h in 4% PFA before being processed in 30% sucrose-TBS at 4°C. After cryopreservation, coronal sections were cut rostro-caudally using a freezing microtome (Frigomobil, Reichert-Jung, Vienna, Austria); six series of equidistant sections were collected using stereological systematic random sampling principles (see below). Free-floating sections were initially blocked with TBS 0.1 M, pH 7.3 plus 0.4% Triton X-100 and 10% bovine serum albumin (BSA) for 1 h at room temperature. Next, sections were washed three times with TBS, and incubated with PV antibody (anti-rabbit PV25, Swant, Marly, Switzerland) at a dilution of 1:1000 and with Vicia Villosa Agglutinin (biotinylated-VVA, Reactolab, Servion, Switzerland) at a concentration of 10 μg/ml in TBS containing MgCl<sub>2</sub>, MnCl<sub>2</sub>, CaCl<sub>2</sub> (final salt concentration: 0.1 mM each) overnight at 4°C. Sections were rinsed once with TBS, then twice with Tris-HCl 0.1 M, pH 8.2; they were then incubated (protected from light) at room temperature with anti-rabbit Cy3-conjugated antibody (1:200 dilution) and Cy2 streptavidin-conjugated antibody (at a dilution of 1:200, from Milan Analytic AG, Switzerland) in Tris-HCl. DAPI staining allowed to visualize nuclei of fixed cells (1:1000 dilution, LuBio Science GmbH, Luzern, Switzerland) in PBS 0.1 M, pH 7.4. After final rinsing, slides were coverslipped with Hydromount (National Diagnostics, Atlanta, GO, USA).</p>
</sec>
<sec>
<title>Stereological Quantification</title>
<p>We used the optical fractionator method (<xref ref-type="bibr" rid="B97">West et al., 1991</xref>) to estimate the total number of PV-positive (PV<sup>+</sup>) and Vicia Villosa Agglutinin-binding (VVA<sup>+</sup>) neurons in brain regions of interest (ROIs) using the Stereo Investigator system (Version 11, MicroBrightField, Williston, VT, USA). The Stereo Investigator system was connected to a Zeiss Axioplan microscope with a motorized x-y stage (Ludl Electronic Products, LTD, NY, USA) and coupled to a Hamamtsu Orca Camera. ROIs were defined based on stereotactic coordinates provided by the Paxinos and Franklin atlas (<xref ref-type="bibr" rid="B74">Paxinos, 2001</xref>). The mPFC was defined at 1.94 to 1.10 mm from bregma comprising the anterior cingulate cortex, prelimbic area and infralimbic area; the corpus callosum, the midline between the hemispheres and fissura longitudinalis cerebri served as borders. The striatum (caudoputamen) was defined at 1.10 to –0.82 mm from bregma; the lateral ventricle, corpus callosum, capsula externa and globus pallidus externum served as borders, whereas the commisura anterior and rhinal fissure served as reference points. The SSC was defined at 1.94 to –1.82 mm from bregma; the corpus callosum and capsula externa served as borders, whereas the lateral ventricle, cingulum, hippocampus and outer brain curvature served as reference points. Cell counting was carried out on images obtained with oil immersion objective lenses (100x; NA = 1.40 and 63x; NA = 1.30). The volume of the analyzed brain structure was determined using the Cavalieri estimator (<xref ref-type="bibr" rid="B40">Gundersen et al., 1988</xref>). Five animals were analyzed per group, with pups from at least 3 different litters for each group. All results obtained from stereological quantification are reported in <bold>Table <xref ref-type="table" rid="T3">3</xref></bold>.</p>
</sec>
<sec>
<title>Counting Criteria</title>
<p>Sampling parameters are reported in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>. VVA<sup>+</sup> and PV<sup>+</sup> cells were counted independently and according to the following criteria: (1) Well visible DAPI-stained nucleus; (2) well-defined perineuronal net (PNN) with a web-/lattice-like morphology for VVA<sup>+</sup> cells; examples are shown in <bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>. (3) PV staining surrounding the DAPI-stained nucleus for PV<sup>+</sup> neurons. The thickness of individual sections was measured at every fifth sampling location, and the mean of all measurements was used for all computations. At each selected location, the microscope was focused down through the disector sample in order to count any positive cell within that particular counting frame according to disector counting rules. Of importance, the cell number estimate is legitimate, even if the tissue volume changes during processing, because the fractionator method does not necessitate a measurement of tissue volume or any other dimensional quality. The total number of cells (N) in the selected ROIs was estimated as summarized by <xref ref-type="bibr" rid="B97">West et al. (1991</xref>, <xref ref-type="bibr" rid="B96">1996</xref>) using the equation:</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Stereological sampling parameters.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Brain region</th>
<th align="left" colspan="1" rowspan="1" valign="top">Cutting plane</th>
<th align="left" colspan="1" rowspan="1" valign="top">No. of sections</th>
<th align="left" colspan="1" rowspan="1" valign="top">Section evaluation interval (μm)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Height of disector (μm)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Guard zone (μm)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Counting frame area (μm)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Sampling grid area (μm)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Measured section thickness mean (μm)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Cavalieri grid size (μm)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Striatum</td>
<td align="left" colspan="1" rowspan="1" valign="top">Coronal</td>
<td align="left" colspan="1" rowspan="1" valign="top">6–7</td>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top">20.0</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">110 × 90</td>
<td align="left" colspan="1" rowspan="1" valign="top">350 × 350</td>
<td align="left" colspan="1" rowspan="1" valign="top">21.06</td>
<td align="left" colspan="1" rowspan="1" valign="top">150 × 150</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SSC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Coronal</td>
<td align="left" colspan="1" rowspan="1" valign="top">14–15</td>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top">20.0</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">70 × 55</td>
<td align="left" colspan="1" rowspan="1" valign="top">450 × 450</td>
<td align="left" colspan="1" rowspan="1" valign="top">21.76</td>
<td align="left" colspan="1" rowspan="1" valign="top">200 × 200</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">mPFC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Coronal</td>
<td align="left" colspan="1" rowspan="1" valign="top">4</td>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top">20.0</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.5</td>
<td align="left" colspan="1" rowspan="1" valign="top">90 × 70</td>
<td align="left" colspan="1" rowspan="1" valign="top">150 × 200</td>
<td align="left" colspan="1" rowspan="1" valign="top">20.80</td>
<td align="left" colspan="1" rowspan="1" valign="top">100 × 100</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p><bold>Representative images of PV and VVA co-localization from PND25 mouse cortex. (A)</bold> PV<sup>+</sup> cells (red) are enwrapped by VVA<sup>+</sup> perineuronal nets (green). Slices were counterstained with DAPI (blue). <bold>(B)</bold> Higher magnification of the boxes outlined in A. Arrowheads point at the PV<sup>+</sup>VVA<sup>+</sup> double-positive cells that are in focus. Scale bar: <bold>(A)</bold> 50 μm; <bold>(B)</bold> 20 μm.</p>
</caption>
<graphic xlink:href="fnmol-09-00150-g001"></graphic>
</fig>
<disp-formula id="E1">
<mml:math id="M1">
<mml:mrow>
<mml:mtext>N</mml:mtext>
<mml:mo> </mml:mo>
<mml:mo>=</mml:mo>
<mml:mo> </mml:mo>
<mml:mstyle displaystyle="true">
<mml:mo>∑</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi>Q</mml:mi>
<mml:mo>−</mml:mo>
</mml:msup>
</mml:mrow>
</mml:mstyle>
<mml:mo> </mml:mo>
<mml:mo>×</mml:mo>
<mml:mo> </mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mi>s</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>f</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo> </mml:mo>
<mml:mo>×</mml:mo>
<mml:mo> </mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>f</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo> </mml:mo>
<mml:mo>×</mml:mo>
<mml:mo> </mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mi>t</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>f</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
<p>where Q<sup>-</sup> signifies the number of objects (counts), and <italic>ssf, asf</italic>, and <italic>tsf</italic> correspond to the section sampling fraction, the area sampling fraction and the thickness sampling fraction, respectively. The accuracy of the estimates N is defined by the coefficient of error CE (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>), which represents the sampling error related to the counting noise, systematic uniform random sampling and variances in section thickness (<xref ref-type="bibr" rid="B41">Gundersen et al., 1999</xref>). For most biological samples, a CE value of 0.10 is largely accepted. CEs for both <italic>m</italic> = 1 and <italic>m</italic> = 0 are provided in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold> and are expected to bracket the true CE values of the estimates. In our double-labeling experiments, strictly individual fluorescence images for either PV<sup>+</sup> or VVA<sup>+</sup> structures were counted as reported before (<xref ref-type="bibr" rid="B33">Filice et al., 2016</xref>) without crosschecking the other channel. This ascertained that a cell (or a small part of a cell resulting from the sectioning) with “weak” staining intensity (i.e., below the predefined threshold) and/or characterized by an “atypical” shape (not easily discernable as cell-like) was considered negative, even if a check of the other channel would have probably identified this cell/cell segment as positive for the second marker.</p>
</sec>
<sec>
<title>RT-qPCR</title>
<p>Mice were euthanized by cervical dislocation and the brain was quickly removed and put in ice-cold 0.9% saline solution. The brain was cut in half along the midline and the cerebellum was removed. The hippocampus and striatum were dissected by carefully removing (pulling) these structures as described in Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S2</xref>. The remaining parts of the brain consisting essentially of cortex (approximately 80% of the total volume) and to minor extent (&lt;20%) subcortical structures including thalamus and pallidum were collected as “forebrain” samples. All tissue samples were snap-frozen in liquid nitrogen and stored at –80°C for further use. The left hemisphere was always dissected first and used for qRT-PCR. Total RNA was extracted from mouse brain tissue (striatum and “forebrain” from the left hemisphere) using the peqGold TRIzol reagent (Peqlab, VWR International GmbH, Erlangen, Germany). cDNA was synthesized using ThermoFisher’s Verso cDNA Synthesis Kit (ThermoFisher, Lausanne, Switzerland). qRT-PCR was carried out to examine the expression of mRNA of the <italic>18S</italic> rRNA, <italic>Ubc, Pvalb, Gad67, Kcnc1, Kcnc2, Kcns3, Hcn1, Hcn2</italic>, and <italic>Hcn4</italic> genes using the universal 2X KAPA SYBR FAST qPCR Master Mix (Axonlab AG, Mont-sur-Lausanne, Switzerland). Details about the primer sequences are listed in <bold>Table <xref ref-type="table" rid="T2">2</xref></bold>. Gene expression quantitation was carried out in a DNA thermal cycler (Corbett Rotor gene 6000, QIAGEN Instruments AG, Hombrechtikon, Switzerland), according to the following two-steps protocol: a denaturation step of 95°C for 3 min; 40 cycles of denaturation at 95°C for 3 s and annealing/extension/data acquisition ranging from 52 to 62°C for 20 s. The housekeeping genes 18S ribosomal RNA (<italic>18S</italic>) or ubiquitin C (<italic>Ubc</italic>) were used as endogenous controls to normalize the mRNA content for each sample. In the second cohort of animals, <italic>Ubc</italic> mRNA signals were found to show lower variability (smaller S.D.) compared to <italic>18S</italic>, both within individual animals and within the groups (VPA vs. control, data not shown). Thus <italic>Ubc</italic> was used to normalize levels of <italic>Kcnc2, Kcns3, Gad67, Hcn1, Hcn2</italic>, and <italic>Hcn4</italic> mRNA levels in the striatum of these animals. However, normalization with <italic>18S</italic> mRNA levels resulted in essentially similar values. mRNA levels were quantified by the 2<sup>-ΔΔCt</sup> method and normalized to (I) housekeeping genes and furthermore (II) to the control mice group as described before (<xref ref-type="bibr" rid="B59">Livak and Schmittgen, 2001</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>qRT-PCR primers.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Primer</th>
<th align="center" colspan="1" rowspan="1" valign="top">Sequence 5′–3′</th>
<th align="left" colspan="1" rowspan="1" valign="top">Nt position</th>
<th align="center" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="center" colspan="1" rowspan="1" valign="top">Gene accession number</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pvalb</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: TGTCGATGACAGACGTGCTC Rev: TTCTTCAACCCCAATCTTGC</td>
<td align="left" colspan="1" rowspan="1" valign="top">24–43 309-328</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Pvalb</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_013645</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">18S rRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: TCAAGAACGAAAGTCGGAGGTT Rev: GGACATCTAAGGGCATCACAG</td>
<td align="left" colspan="1" rowspan="1" valign="top">1026–1047 1493-1513</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Rn18S</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NR_003278</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">UBC</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: CGGAGTCGCCCGAGGTCACA Rev: CTGCATCGTCTCTCTCACGGAGTT</td>
<td align="left" colspan="1" rowspan="1" valign="top">23–42 94-117</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Ubc</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_019639</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GAD67</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: AATCTTGCTTCAGTAGCCTTCG Rev: TGTCTTCAAAAACACTTGTGGG</td>
<td align="left" colspan="1" rowspan="1" valign="top">2979–3000 3178–3199</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Gad1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_001312900</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">K<sub>v</sub>3.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: GTGCCGACGAGTTCTTCTTC Rev: GTCATCTCCAGCTCGTCCTC</td>
<td align="left" colspan="1" rowspan="1" valign="top">1362–1381 1646–1665</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Kcnc1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_001112739</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">K<sub>v</sub>3.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: AGATCGAGAGCAACGAGAGG Rev: GGTGGCGATCGAAGAAGAAT</td>
<td align="left" colspan="1" rowspan="1" valign="top">72–91 379–398</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Kcnc2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_001025581</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">K<sub>v</sub>9.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: CCCTGGACAAGATGAGGAAC Rev: TTGATGCCCCAGTACTCGAT</td>
<td align="left" colspan="1" rowspan="1" valign="top">465–484 745–764</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Kcns3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_173417</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HCN1</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: CTCAGTCTCTTGCGGTTATTACG Rev: TGGCGAGGTCATAGGTCAT</td>
<td align="left" colspan="1" rowspan="1" valign="top">1138–1160 1210–1228</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Hcn1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_010408</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HCN2</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: ATCGCATAGGCAAGAAGAACTC Rev: CAATCTCCTGGATGATGGCATT</td>
<td align="left" colspan="1" rowspan="1" valign="top">1936–1957 2017–2037</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Hcn2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_008226</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HCN4</td>
<td align="left" colspan="1" rowspan="1" valign="top">For: GCATGATGCTTCTGCTGTGT Rev: GCTTCCCCCAGGAGTTATTC</td>
<td align="left" colspan="1" rowspan="1" valign="top">1268–1287 1371–1390</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Hcn4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_001081192</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Western Blot Analyses</title>
<p>Frozen brain tissue from the dissected second (right) hemispheres as described above were homogenized and soluble or membrane proteins extracted for Western blotting experiments as described before (<xref ref-type="bibr" rid="B79">Racay et al., 2006</xref>; <xref ref-type="bibr" rid="B64">Maetzler et al., 2009</xref>). Denatured proteins (30 μg) were separated by SDS-PAGE (10–12.5%). After electrophoresis, the proteins were transferred on nitrocellulose membranes (MS solution, Chemie Brunschwig, Basel, Switzerland). The membranes were then blocked with 5% bovine serum albumin (BSA) in TBS for 60 min at room temperature and incubated with primary antibodies: rabbit anti-PV25 (Swant, Marly, Switzerland), rabbit anti-GAPDH (Sigma–Aldrich, Buchs, Switzerland) diluted 1:10,000, rabbit anti-K<sub>v</sub>3.1b (Merck Millipore, Schaffhausen, Switzerland), rabbit anti-HCN1 (Alomone Labs, Jerusalem, Israel) diluted 1:200 in 2% BSA in TBS-T overnight at 4°C. Membranes were washed three times in TBS-T and incubated for 1 h with secondary antibody (goat anti-rabbit IgG HRP-conjugated, Sigma–Aldrich, Buchs, Switzerland) diluted at 1:10,000 in TBS-T. Finally, membranes were repeatedly rinsed in TBS-T and developed using ECL (Merck Millipore, Schaffhausen, Switzerland). Bands visualized by ECL were quantified using Image Studio Light Version 5.0. GAPDH signals were used as loading control.</p>
</sec>
<sec>
<title>Statistical Analysis and Cell Number Estimates</title>
<p>Stereological data, mRNA and protein levels were compared between groups by the Student’s <italic>t</italic>-test. Data were analyzed using the GraphPad Prism 6 software (San Diego, USA). As no significant differences were observed when comparing ROIs in the two hemispheres of the same mouse, analyses were carried out with the pooled data of both hemispheres. The morphological data were initially checked for normal distribution by the Kolmogorov–Smirnov test and further analyzed with the Student’s <italic>t</italic>-test. A <italic>p</italic>-value &lt; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>VPA-Treated Mice are Healthy and Develop Normally</title>
<p>Different protocols for the VPA animal model of ASD have been previously applied. We chose to use a dose of 600 mg/kg administered at GD12, because of the well-described behavioral phenotype observed in these mice (<xref ref-type="bibr" rid="B38">Gottfried et al., 2013</xref>; <xref ref-type="bibr" rid="B63">Mabunga et al., 2015</xref>). Oral gavage was performed to accurately control the dose and minimize risk to harm the pregnant females or the fetus. We did not detect any physical malformation or conspicuous features in the pups from VPA-treated mothers, except for five pups from two different litters that manifested few hairless spots at PND15. However, occurrence of hair loss is a characteristic of the C57Bl/6J and related mouse strains. Litter size, sex distribution and weight of the pups were not different between VPA and control mice (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref>).</p>
</sec>
<sec>
<title>PV Expression Levels, But Not Pvalb Neuron Numbers are Decreased in the Striatum of VPA Mice</title>
<p>To evaluate the involvement of Pvalb neurons in the VPA mouse model, we performed stereology-based analysis of VPA mice at PND25 ± 1. The optical fractionator method was used to reliably quantify cell numbers in three ASD-associated brain regions, namely the striatum, medial prefrontal cortex (mPFC) and somatosensory cortex (SSC). Coefficient of error (CE) values ranged from 0.06 to 0.11 (<bold>Table <xref ref-type="table" rid="T3">3</xref></bold>) indicating a high precision of the estimates for both PV<sup>+</sup> and VVA<sup>+</sup> populations (<xref ref-type="bibr" rid="B41">Gundersen et al., 1999</xref>). One of the most crucial points when counting PV<sup>+</sup> cells stained with an anti-PV antibody, is, whether the absence of a signal signifies “Pvalb neuron loss” or rather “PV down-regulation”. Therefore, in addition to counting PV<sup>+</sup> cells via anti-PV immunostaining, we simultaneously quantified the number of Vicia Villosa Agglutinin VVA<sup>+</sup> cells, i.e., neurons surrounded by PNNs in the same brain regions to obtain an alternative estimate for the number of Pvalb cells. VVA is a lectin that binds to <italic>N</italic>-acetylgalactosamine residues of PNNs, which specifically surround Pvalb neurons (<xref ref-type="bibr" rid="B43">Hartig et al., 1992</xref>; <xref ref-type="bibr" rid="B45">Haunso et al., 2000</xref>), as also shown in our previous study (<xref ref-type="bibr" rid="B33">Filice et al., 2016</xref>). VVA<sup>+</sup> cells were considered to serve as a correlate for Pvalb neurons; a typical example of PV and VVA co-localization is shown in <bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>. In the selected cortical region, essentially all PV<sup>+</sup> cells are surrounded by a PNN identified as VVA<sup>+</sup> cells. The one cell showing strong PNN labeling, but weak to none PV staining was mostly out of focus and cut very tangentially, i.e. containing a minimal part of the somatic region within the section, also evidenced by the low to absent DAPI staining.</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Mean total number of PV<sup>+</sup> and VVA<sup>+</sup> cells in the striatum, SSC and mPFC of saline- and VPA-exposed mice.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<th align="center" colspan="4" rowspan="1" valign="top">Striatum PV<sup>+</sup><hr/></th>
<th align="center" colspan="4" rowspan="1" valign="top">Striatum VVA<sup>+</sup><hr/></th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<th align="center" colspan="1" rowspan="1" valign="top">Mean</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<italic>SD</italic>
</th>
<th align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic>-value</th>
<th align="center" colspan="1" rowspan="1" valign="top">CE<sub>m = 0</sub>/<sub>m = 1</sub> ≤</th>
<th align="center" colspan="1" rowspan="1" valign="top">Mean</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<italic>SD</italic>
</th>
<th align="center" colspan="1" rowspan="1" valign="top"><italic>P</italic>-value</th>
<th align="center" colspan="1" rowspan="1" valign="top">CE<sub>m = 0</sub>/<sub>m = 1</sub> ≤</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Control VPA</td>
<td align="center" colspan="1" rowspan="1" valign="top">21′251 18’090</td>
<td align="center" colspan="1" rowspan="1" valign="top">1051 1790</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0093</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.09/0.06 0.10/0.07</td>
<td align="center" colspan="1" rowspan="1" valign="top">26’518 27’225</td>
<td align="center" colspan="1" rowspan="1" valign="top">460 3076</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.6249</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.09/0.06 0.09/0.06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="4" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="4" rowspan="1" valign="top">
<bold>SSC PV<sup>+</sup></bold>
<hr/>
</td>
<td align="center" colspan="4" rowspan="1" valign="top">
<bold>SSC VVA<sup>+</sup></bold>
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>Mean</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>SD</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>P</italic>-value</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>CE<sub>m = 0</sub>/<sub>m = 1</sub> ≤</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>Mean</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>SD</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>P</italic>-value</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>CE<sub>m = 0</sub>/<sub>m = 1</sub> ≤</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="4" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Control VPA</td>
<td align="center" colspan="1" rowspan="1" valign="top">121′971 128′896</td>
<td align="center" colspan="1" rowspan="1" valign="top">4987 14′897</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.3532</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.07/0.06 0.08/0.06</td>
<td align="center" colspan="1" rowspan="1" valign="top">143’397 153’087</td>
<td align="center" colspan="1" rowspan="1" valign="top">8093 13’281</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.2010</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.06/0.05 0.08/0.07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="4" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="4" rowspan="1" valign="top">
<bold>mPFC PV<sup>+</sup></bold>
<hr/>
</td>
<td align="center" colspan="4" rowspan="1" valign="top">
<bold>mPFC VVA<sup>+</sup></bold>
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>Mean</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>SD</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>P</italic>-value</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>CE<sub>m = 0</sub>/<sub>m = 1</sub> ≤</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>Mean</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>SD</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>P</italic>-value</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>CE<sub>m = 0</sub>/<sub>m = 1</sub> ≤</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="4" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Control VPA</td>
<td align="center" colspan="1" rowspan="1" valign="top">6622 6760</td>
<td align="center" colspan="1" rowspan="1" valign="top">242 1476</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.8415</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.11/0.07 0.10/0.07</td>
<td align="center" colspan="1" rowspan="1" valign="top">7211 7380</td>
<td align="center" colspan="1" rowspan="1" valign="top">713 1423</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.8191</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.10/0.07 0.11/0.07</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>PV<sup>+</sup> and VVA<sup>+</sup> cells were counted independently without crosschecking the other channel to ensure unbiased cell estimates. In the striatum of control mice, ∼90% of PV<sup>+</sup> cells were also VVA<sup>+</sup> (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>), whereas in the cortex, the selectivity was slightly lower with ∼75% of PV<sup>+</sup> cells also being positive for VVA (<bold>Figures <xref ref-type="fig" rid="F3">3A</xref> and <xref ref-type="fig" rid="F4">4A</xref></bold>). Within the pool of VVA<sup>+</sup> cells, ∼70% and ∼65% of cells in control mice were also identified as PV<sup>+</sup> in the striatum (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>) and the cortex (<bold>Figures <xref ref-type="fig" rid="F3">3A</xref></bold> and <bold><xref ref-type="fig" rid="F4">4A</xref></bold>), respectively. Similar values were obtained in previous studies (<xref ref-type="bibr" rid="B99">Ye and Miao, 2013</xref>; <xref ref-type="bibr" rid="B33">Filice et al., 2016</xref>). The number of PV<sup>+</sup> cells in the striatum of VPA mice was reduced by ∼15% (<italic>p</italic> = 0.0093) compared to controls (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>). However, there was no difference in the number of VVA<sup>+</sup> cells between the two groups in the same region (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>), indicating that the number of Pvalb neurons was not decreased in VPA mice. We thus determined the number of double-labeled cells in the striatum. In saline-treated control mice, 71% of VVA<sup>+</sup> cells were also PV<sup>+</sup>, whereas in VPA mice, this ratio was significantly decreased by ∼15% (<italic>p</italic> = 0.0448) (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>). This hinted that PV protein expression levels might be down-regulated in VPA mice. No difference was seen for PV-positive (PV<sup>+</sup>) cells that also stained positive for VVA in the three investigated regions (PV pool; <bold>Figures <xref ref-type="fig" rid="F2">2A</xref>, <xref ref-type="fig" rid="F3">3A</xref></bold>, and <bold><xref ref-type="fig" rid="F4">4A</xref></bold>), suggesting that globally VVA<sup>+</sup> PNNs were not affected by VPA exposure. Representative immunofluorescence images of the striatum are shown in <bold>Figure <xref ref-type="fig" rid="F2">2D</xref></bold>. Although cell estimates obtained by the fractionator method are absolute, we decided to determine the volume of the analyzed ROIs to exclude major macroscopically discernable developmental abnormalities. The volume of the striatum, as measured by the Cavalieri estimator, was not different between VPA and control mice (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>). To certify that PV expression was decreased in VPA mice, PV levels were determined by qRT-PCR and Western blotting. In line with the stereological counts, striatal <italic>Pvalb</italic> mRNA levels were decreased by ∼50% (<italic>p</italic> = 0.0246) in VPA mice compared to control animals (<bold>Figure <xref ref-type="fig" rid="F2">2B</xref></bold>). Likewise, PV protein expression levels in the striatum were decreased by ∼30% (<italic>p</italic> = 0.0218) in VPA mice, fully supporting the stereological findings (<bold>Figure <xref ref-type="fig" rid="F2">2C</xref></bold>). GAPDH was used to normalize the PV signals on the Western blots (<bold>Figure <xref ref-type="fig" rid="F2">2C</xref></bold>). Since all Pvalb neurons in the striatum are GABAergic and moreover express the potassium voltage-gated channel subfamily C member 1 (KCNC1/K<sub>v</sub>3.1) (<xref ref-type="bibr" rid="B18">Chow et al., 1999</xref>) and subfamily S member 3 (KCNS3/K<sub>v</sub>9.3) (<xref ref-type="bibr" rid="B35">Georgiev et al., 2012</xref>), we quantified transcript levels for glutamic acid decarboxylase 67 (<italic>Gad67</italic>), the major GABA-synthetizing enzyme in the brain, <italic>Kcnc1</italic> and <italic>Kcns3</italic> in VPA and control mice. For all 3 Pvalb neuron markers, transcript levels were not different in the striatum between VPA and control mice (<bold>Figures <xref ref-type="fig" rid="F5">5B1,D,F</xref></bold>). Altogether, these results strongly indicated that VPA treatment resulted in decreased striatal PV expression. Reduced PV expression was also shown before in the striatum of PV<sup>+/-</sup> mice and moreover, in the same region in Shank3B<sup>-/-</sup> knockout mice (<xref ref-type="bibr" rid="B33">Filice et al., 2016</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p><bold>(A)</bold> Left: Stereological estimations of PV<sup>+</sup> (black) and VVA<sup>+</sup> (gray) cells in the striatum of PND25 <italic>in utero</italic> saline-(CON) or VPA-treated male mice (<italic>N</italic> = 5 each). Significant differences are observed in PV<sup>+</sup> cells between CON and VPA mice (<italic>P</italic>-value &lt; 0.01). Asterisks represent <sup>∗</sup><italic>P</italic> ≤ 0.05, <sup>∗∗</sup><italic>P</italic> ≤ 0.01, respectively. Middle: percentage of PV<sup>+</sup> cells surrounded by VVA (black) and VVA<sup>+</sup> cells showing PV expression (gray) in CON and VPA mice. Right: Volume of the ROI; i.e., the striatum. <bold>(B)</bold> qRT-PCR values from PND25 mice representing striatal mRNA levels were normalized to <italic>18S</italic> mRNA levels and expressed as fold change compared to CON (<italic>N</italic> = 6 mice each). <bold>(C)</bold> Left: Quantitative Western blot analysis of striatal samples of PND25 CON and VPA mice (<italic>N</italic> = 6 each). Quantification of PV protein levels in the striatum is shown. GAPDH signals served as loading controls and were used for the normalization of the PV signals. Results are expressed as a percentage of normalized PV levels measured in a mixture of lysates from six WT striatums that was loaded on all membranes. Right: Representative Western blot signals. <bold>(D)</bold> Representative PV immunofluorescence images from the striatum of a CON and VPA mouse are shown. Scale bar: 200 μm. All data expressed as mean ± SEM.</p>
</caption>
<graphic xlink:href="fnmol-09-00150-g002"></graphic>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p><bold>(A)</bold> Left: Stereological estimations of PV<sup>+</sup> (black) and VVA<sup>+</sup> (gray) cells in the SSC of PND25 <italic>in utero</italic> saline (CON) or VPA-treated male mice (<italic>N</italic> = 5 each). Middle: percentage of PV<sup>+</sup> cells surrounded by VVA (black) and VVA<sup>+</sup> cells showing PV expression (gray) in CON and VPA mice. Right: Volume of the ROI; i.e., the SSC. <bold>(B)</bold> Representative PV immunofluorescence images from the SSC of a CON and VPA mouse are shown. Scale bar: 200 μm. All data are expressed as mean ± SEM.</p>
</caption>
<graphic xlink:href="fnmol-09-00150-g003"></graphic>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p><bold>(A)</bold> Left: Stereological estimations of PV<sup>+</sup> (black) and VVA<sup>+</sup> (gray) cells in the mPFC of PND25 <italic>in utero</italic> saline (CON) or VPA treated male mice (<italic>N</italic> = 5 each). Middle: percentage of PV<italic><sup>+</sup></italic> cells surrounded by VVA (black) and VVA<sup>+</sup> cells showing PV expression (gray) in CON and VPA mice. Right: Volume of the ROI; i.e., the mPFC. Asterisks represent <sup>∗</sup><italic>P</italic> ≤ 0.05. <bold>(B)</bold> Representative PV immunofluorescence images from the mPFC of a CON and VPA mouse are shown. Scale bar: 200 μm. All data are expressed as mean ± SEM.</p>
</caption>
<graphic xlink:href="fnmol-09-00150-g004"></graphic>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p><bold>qRT-PCR values from PND25 mice representing mRNA levels for (A1)</bold>
<italic>Pvalb</italic>, <bold>(B1)</bold>
<italic>Kcnc1</italic>, <bold>(C1)</bold>
<italic>Hcn1</italic>, <bold>(D)</bold>
<italic>Gad67</italic>, <bold>(E)</bold>
<italic>Kcnc2</italic>, <bold>(F)</bold>
<italic>Kcns3</italic>, <bold>(G)</bold>
<italic>Hcn2</italic>, and <bold>(H)</bold>
<italic>Hcn4</italic> were normalized to <italic>18S</italic> or <italic>Ubc</italic> mRNA levels and expressed as fold change compared to CON (N = 5 mice each; for <italic>Pvalb N</italic> = 6 mice each). <bold>(A2,B2,C2)</bold> Quantitative Western blot analysis of forebrain samples of PND25 CON and VPA mice (<italic>N</italic> = 5 mice each). Quantification of PV <bold>(A2)</bold>, K<sub>v</sub>3.1b <bold>(B2)</bold>, and HCN1 <bold>(C2)</bold> protein levels in the forebrain samples are shown. Asterisks represent <sup>∗</sup><italic>P</italic> ≤ 0.05, <sup>∗∗∗</sup><italic>P</italic> ≤ 0.001. GAPDH signals served as loading controls and were used for the normalization of the target protein signals. Results are expressed as a percentage of normalized PV/K<sub>v</sub>3.1b/HCN1 levels measured in a mixture of lysates from six WT forebrains that was loaded on all membranes. Representative Western blot signals for PV <bold>(A2)</bold>, K<sub>v</sub>3.1b <bold>(B2)</bold>, and HCN1 <bold>(C2)</bold> are shown. All data are expressed as mean ± SEM.</p>
</caption>
<graphic xlink:href="fnmol-09-00150-g005"></graphic>
</fig>
</sec>
<sec>
<title>Selected Cortical Regions (mPFC, SSC) of VPA Mice Show Unaltered Pvalb Neuron Numbers</title>
<p>Pvalb neurons in the rat and mouse VPA model have previously been investigated and animals were reported to exhibit a decreased number of PV<sup>+</sup> cells, considered as the result of Pvalb neuronal loss in the neocortex and the colliculi superior (superficial and intermediate/deep layers), respectively (<xref ref-type="bibr" rid="B37">Gogolla et al., 2009</xref>; <xref ref-type="bibr" rid="B24">Dendrinos et al., 2011</xref>). To confirm these findings, but at the same time to investigate the alternate possibility that the decrease in PV<sup>+</sup> neurons was the result of PV down-regulation, we examined two ASD-associated cortical structures, namely SSC and mPFC. Stereological analysis of both regions did not reveal altered numbers of Pvalb neurons in VPA compared to control mice, since neither the number of PV<sup>+</sup> cells nor the one for VVA<sup>+</sup> cells was different from control mice (<bold>Figures <xref ref-type="fig" rid="F3">3A</xref></bold> and <bold><xref ref-type="fig" rid="F4">4A</xref></bold>). Representative immunofluorescence images of the SSC and mPFC are shown in <bold>Figures <xref ref-type="fig" rid="F3">3B</xref></bold> and <bold><xref ref-type="fig" rid="F4">4B</xref></bold>, respectively. Of note, the volume of the mPFC was slightly increased by ∼20% (<italic>p</italic> = 0.0286) in VPA mice compared to control mice (<bold>Figure <xref ref-type="fig" rid="F4">4A</xref></bold>). Indeed, brain overgrowth during infancy is a hallmark of ASD pathophysiology that has been observed in human cases (<xref ref-type="bibr" rid="B21">Courchesne et al., 2011</xref>), in VPA mice (<xref ref-type="bibr" rid="B36">Go et al., 2012</xref>) and several ASD mouse models including Shank3<sup>-/-</sup> mice (<xref ref-type="bibr" rid="B27">Ellegood et al., 2015</xref>). Nonetheless, calculating the density of Pvalb cells per unit volume did not result in a significantly decreased number of Pvalb neurons in the mPFC of VPA mice. The volume of the SSC was similar between VPA and control mice (<bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>).</p>
</sec>
<sec>
<title>PV Expression Levels are Unchanged in Forebrain Lysates, but Levels of K<sub>v</sub>3.1b are Decreased, While Levels of HCN1 are Increased</title>
<p>Consistent with IHC stereology results from mPFC and SSC (<bold>Figures <xref ref-type="fig" rid="F3">3</xref></bold> and <bold><xref ref-type="fig" rid="F4">4</xref></bold>) and global appearance of PV staining in the cortex (data not shown), <italic>Pvalb</italic> mRNA and protein levels from forebrain samples were similar between groups (<bold>Figure <xref ref-type="fig" rid="F5">5A1,A2</xref></bold>). To avoid cross-contamination, the forebrain tissue mostly comprising neocortical tissue, but also including the subcortical structures thalamus and pallidus was not further dissected; thus, reduced spatial resolution is a limitation in the qRT-PCR and Western blot analyses. Next, we quantified G<italic>ad67, Kcnc1</italic> (K<sub>v</sub>3.1), and <italic>Kcns3</italic> (K<sub>v</sub>9.3) mRNA levels in the forebrain samples. <italic>Gad67</italic> expression was not decreased in VPA mice; rather slightly increased, supporting the finding that there was no loss of GABAergic interneurons in VPA mice (<bold>Figure <xref ref-type="fig" rid="F5">5D</xref></bold>). Moreover, transcript levels of <italic>Kcns3</italic>, which is selectively expressed in Pvalb neocortical neurons, were even slightly, but not significantly (<italic>p</italic> = 0.1095) increased in VPA compared to control mice (<bold>Figure <xref ref-type="fig" rid="F5">5F</xref></bold>), in support of an unaltered (certainly not decreased) number of Pvalb neurons. The precise localization of K<sub>v</sub>9.3 giving rise to a <italic>Kcns3</italic> transcript signal in the striatum is currently unknown. Irrespective of its origin, <italic>Kcns3</italic> was unaltered in the VPA mice (<bold>Figure <xref ref-type="fig" rid="F5">5F</xref></bold>).</p>
<p>In contrast, forebrain mRNA levels of <italic>Kcnc1</italic> coding for K<sub>v</sub>3.1 were significantly decreased by ∼40% in VPA mice (<italic>p</italic> = 0.0114) (<bold>Figure <xref ref-type="fig" rid="F5">5B1</xref></bold>). This decrease was also confirmed at the protein level: K<sub>v</sub>3.1b protein levels determined by Western blot analysis were decreased to a similar extent, i.e., ∼40% reduction (<italic>p</italic> = 0.0002) of K<sub>v</sub>3.1b in forebrain samples of VPA mice compared to controls (<bold>Figure <xref ref-type="fig" rid="F5">5B2</xref></bold>), a finding in line with previous results from lysates of SSC of PND15-21 VPA mice (<xref ref-type="bibr" rid="B49">Iijima et al., 2016</xref>). We estimate that these results reflect decreased expression of K<sub>v</sub>3.1 channels rather than loss of neurons expressing K<sub>v</sub>3.1, since the overlap between cortical Pvalb neurons (unchanged in mPFC and SSC; <bold>Figures <xref ref-type="fig" rid="F3">3A</xref></bold> and <bold><xref ref-type="fig" rid="F4">4A</xref></bold>) and K<sub>v</sub>3.1b is &gt;95% (<xref ref-type="bibr" rid="B18">Chow et al., 1999</xref>). Since results with respect to Pvalb neurons in VPA mice showed a high similarity with what we had observed before in Shank3B<sup>-/-</sup> mice, i.e., a significant decrease in striatal PV levels (<xref ref-type="bibr" rid="B33">Filice et al., 2016</xref>) and moreover the recent findings that Shank3 mutations resulted in a decrease in hyperpolarization-activated cation (<italic>I</italic><sub>h</sub>) currents likely being the result of decreased HCN3 and HCN4 levels (<xref ref-type="bibr" rid="B100">Yi et al., 2016</xref>), we investigated transcript levels of the various hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in VPA mice including transcript levels of <italic>Hcn1, Hcn2</italic>, and <italic>Hcn4</italic>, the predominant forms expressed in the brain. While <italic>Hcn2</italic> and <italic>Hcn4</italic> transcript levels were unchanged (<bold>Figures <xref ref-type="fig" rid="F5">5G,H</xref></bold>); <italic>Hcn1</italic>, which does not co-localize with Pvalb neurons in the neocortex and the basal ganglia (<xref ref-type="bibr" rid="B70">Morris et al., 2004</xref>) was significantly up-regulated by ∼40% (<italic>p</italic> = 0.0484) in forebrain samples of VPA mice (<bold>Figure <xref ref-type="fig" rid="F5">5C1</xref></bold>). The increase in HCN1 was also verified at the protein level; Western blotting showed a ∼40% increase (<italic>p</italic> = 0.0342) in VPA mice compared to controls (<bold>Figure <xref ref-type="fig" rid="F5">5C2</xref></bold>). Interestingly, when we quantitatively determined transcript levels of <italic>Hcn1, Hcn2</italic>, and <italic>Hcn4</italic> in the striatum, no differences were observed between VPA and control mice (<bold>Figures <xref ref-type="fig" rid="F5">5C1,G,H</xref></bold>). Finally, we determined mRNA levels of <italic>Kcnc2</italic> (K<sub>v</sub>3.2) to see whether K<sub>v</sub>3.2 quantitatively compensates for the K<sub>v</sub>3.1 deficit. K<sub>v</sub>3.2 is a close relative of K<sub>v</sub>3.1, but co-localizes to a lesser extend with Pvalb neurons (<xref ref-type="bibr" rid="B18">Chow et al., 1999</xref>). There was no difference in forebrain mRNA levels of K<sub>v</sub>3.2 between VPA and control mice (<bold>Figure <xref ref-type="fig" rid="F5">5E</xref></bold>). This was also true for the striatum (<bold>Figure <xref ref-type="fig" rid="F5">5E</xref></bold>). In summary, our results indicate that VPA mice do neither exhibit Pvalb neuron loss nor a decrease in PV expression levels in the forebrain; instead, they display reduced levels of K<sub>v</sub>3.1b in combination with augmented expression of HCN1. The functional implications of these alterations in forebrain regions including the neocortex and the selective down-regulation of PV in the striatum, possibly linked to homeostatic plasticity, are discussed below.</p>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>With far more than 100 putative risk genes and additionally epigenetic and environmental risk factors, the pathophysiology of ASD is extremely heterogeneous and complex. One of the major current scientific aims is therefore to find common pathways that link not only different risk genes, but also epigenetic and environmental risk factors. During embryonic development, not only genetic mutations may lead to aberrant brain development, but also external insults may affect the correct migration and differentiation of neuronal precursor cells. This includes VPA shown to impair normal brain development in humans as well as in rodents. Also at the morpho-functional level, VPA mice and rats exhibit ASD-specific abnormalities such as: decreased neuron numbers in different brain areas (<xref ref-type="bibr" rid="B82">Rodier et al., 1996</xref>; <xref ref-type="bibr" rid="B62">Lukose et al., 2011</xref>; <xref ref-type="bibr" rid="B53">Kataoka et al., 2013</xref>), an increase in a postsynaptic form of long-term potentiation (LTP) between pyramidal cells in the somatosensory cortex (<xref ref-type="bibr" rid="B81">Rinaldi et al., 2008</xref>), and deficits in inhibitory signaling (<xref ref-type="bibr" rid="B66">Markram et al., 2008</xref>; <xref ref-type="bibr" rid="B3">Banerjee et al., 2013</xref>). Altered synaptic transmission in VPA mice or rats is of particular interest, since ASD are broadly characterized by synaptic deficits leading to an E/I imbalance in the brain (<xref ref-type="bibr" rid="B84">Rubenstein and Merzenich, 2003</xref>). Therefore, it is important to explicitly address the question when, where and how alterations/deficits in neuronal signaling occur in an ASD model. In the VPA model, early postnatal enhancement of NMDA receptor-mediated transmission and increased plasticity in the SSC (<xref ref-type="bibr" rid="B80">Rinaldi et al., 2007</xref>) as well as hyper-connectivity and hyper-plasticity of pyramidal synaptic connections in the prefrontal cortex (<xref ref-type="bibr" rid="B81">Rinaldi et al., 2008</xref>) have been reported. Intriguingly, in the same study, layer 5 pyramidal neurons in ∼PND14 mice were found to be less excitable in VPA animals compared to controls (<xref ref-type="bibr" rid="B81">Rinaldi et al., 2008</xref>), a finding that was confirmed in mice for layer 2/3 pyramidal neurons in the mPFC (<xref ref-type="bibr" rid="B95">Walcott et al., 2011</xref>). Since the two developmental deviations (increased NMDA receptor-mediated transmission and hypo-excitability) show the same time line, it was hypothesized that anomalies in one might lead to a homeostatic response to the other (<xref ref-type="bibr" rid="B95">Walcott et al., 2011</xref>) according to the concept of homeostatic synaptic plasticity (<xref ref-type="bibr" rid="B90">Turrigiano, 2011</xref>). Our observed upregulation of HCN1 therefore might represent a possible mechanism mediating such a transient change in intrinsic neuronal properties leading to hypo-excitability secondary to the observed hyper-connectivity and hyper-plasticity in the mPFC in young mice according to findings reported by Rinaldi (<xref ref-type="bibr" rid="B81">Rinaldi et al., 2008</xref>). The difference in intrinsic excitability disappeared in adolescent (&gt;1 month) mice demonstrating the transient nature of plasticity mechanisms (<xref ref-type="bibr" rid="B95">Walcott et al., 2011</xref>). In our study, we found increased levels of HCN1 in the cortex of VPA mice. The various HCN channel members HCN1–4 differ in their tissue distribution, within the brain in particular regions and neuron types and in their activation kinetics. They are responsible for generating hyperpolarization-activated <italic>I</italic><sub>h</sub> currents, important for controlling membrane resting potentials, input resistance, dendritic integration, synaptic transmission and neuronal excitability (<xref ref-type="bibr" rid="B7">Biel et al., 2009</xref>; <xref ref-type="bibr" rid="B5">Benarroch, 2013</xref>). Elimination of HCN subunits or blocking of I<sub>h</sub> currents generally increases dendritic input resistance and leads to hyper-excitability and enhanced neuronal firing (<xref ref-type="bibr" rid="B87">Shah et al., 2004</xref>; <xref ref-type="bibr" rid="B47">Huang et al., 2009</xref>). Inversely, activity-dependent decrease of excitability through enhancement of <italic>I</italic><sub>h</sub> currents is seen in rat hippocampal neurons (<xref ref-type="bibr" rid="B32">Fan et al., 2005</xref>). Moreover, suppressed burst-firing and decreased input resistance due to enhanced <italic>I</italic><sub>h</sub> currents have been observed in thalamo-cortical neurons in the genetic absence epilepsy rat from Strasbourg (GAERS) model, which shows upregulation of HCN1 protein levels (<xref ref-type="bibr" rid="B56">Kuisle et al., 2006</xref>; <xref ref-type="bibr" rid="B10">Cain et al., 2015</xref>). Given that HCN1 is prominently expressed in neocortical pyramidal cell dendrites (<xref ref-type="bibr" rid="B69">Moosmang et al., 1999</xref>; <xref ref-type="bibr" rid="B60">Lorincz et al., 2002</xref>; <xref ref-type="bibr" rid="B70">Morris et al., 2004</xref>), increased levels of HCN1 and subsequent enhancement of <italic>I</italic><sub>h</sub> currents are likely to lower input resistance and thus might contribute to the hypo-excitability observed in cortical pyramidal neurons of VPA rats during the first month of development. Indeed, membrane input resistance in the mPFC and SSC is slightly, yet not significantly lower in VPA compared to control rats (<xref ref-type="bibr" rid="B81">Rinaldi et al., 2008</xref>).</p>
<p>Also altered inhibitory signaling contributes to the pathophysiology of ASD. Impaired pre- and post-synaptic inhibitory transmission in the temporal cortex (<xref ref-type="bibr" rid="B3">Banerjee et al., 2013</xref>), decreased inhibition in the lateral amygdala (<xref ref-type="bibr" rid="B66">Markram et al., 2008</xref>) and a decrease in the PV<sup>+</sup> neuron number assumed to be the result of a loss of PV-expressing neurons in the neocortex (<xref ref-type="bibr" rid="B37">Gogolla et al., 2009</xref>) and the colliculi superiors (<xref ref-type="bibr" rid="B24">Dendrinos et al., 2011</xref>) have been observed in VPA mice and rats. An involvement of the Pvalb neurons in ASD and schizophrenia is nowadays undisputed. However, the question whether Pvalb neurons are indeed lost or simply deficient/reduced in PV protein levels is rarely addressed in an appropriate way, e.g., by using other markers to unequivocally identifying the Pvalb neuron population. Considering that the two possibilities have opposite consequences, this is of great importance: loss of Pvalb neurons leads to decreased inhibition, whereas PV down-regulation has the opposite effect, i.e., by its absence increasing short-term facilitation and thus enhancing inhibition (<xref ref-type="bibr" rid="B86">Schwaller, 2012</xref>). Herein we have shown that the number of Pvalb neurons, as determined by the number of VVA<sup>+</sup> PNN-enwrapped cells, is unchanged in the striatum, mPFC and SSC of VPA mice compared to controls. Thus, the reduced numbers of PV<sup>+</sup> neurons detected in the striatum of VPA mice reflect decreased PV expression levels, also confirmed at mRNA and protein levels, without any indication for Pvalb neuron loss. While PV protein levels were clearly decreased in the striatum of VPA mice, this didn’t occur in the cortex, where instead altered expression of HCN1 and K<sub>v</sub>3.1b was observed (see below). In neurons, PV is essentially implicated in the subtle modulation of Ca<sup>2+</sup> signals and moreover involved in regulating the Ca<sup>2+</sup> homeostasis and subsequently fine-tuning of neuronal signaling (<xref ref-type="bibr" rid="B86">Schwaller, 2012</xref>). The absence of PV in PV<sup>-/-</sup> mice results in enhanced facilitation and modified frequency-specific short-term plasticity at FSI to striatal medium-sized spiny neuron synapses (<xref ref-type="bibr" rid="B72">Orduz et al., 2013</xref>). Assuming a similar mechanism in VPA mice, this might represent an adaptive/homeostatic mechanism to strengthen impaired inhibitory signaling in the striatum of VPA mice by enhancing the output of inhibitory Pvalb neurons. Of note, the absence of PV not only affects the output of the FSI, but also entails modifications in synaptic transmission between the cortical afferences and striatal FSI; in PV<sup>-/-</sup> mice short-term depression of EPSCs is increased in a similar time window (<xref ref-type="bibr" rid="B98">Wohr et al., 2015</xref>) as short-term facilitation is increased in PV-FSI (<xref ref-type="bibr" rid="B72">Orduz et al., 2013</xref>). We did not detect altered levels of PV in the forebrain samples of VPA mice, in contrast to recent findings by <xref ref-type="bibr" rid="B49">Iijima et al. (2016)</xref>, who reported a decrease in PV levels by &gt;20% in lysates from neocortical cortex of PND15-21 mice. This apparent discrepancy might be related to the time point of their analyses: in the period from PND15-25, PV protein levels, the number of PV-immunoreactive neurons or of Pvalb neuron structures (e.g., boutons) increase considerably, e.g., seen in mouse or rat cortex (<xref ref-type="bibr" rid="B1">Alcantara et al., 1993</xref>; <xref ref-type="bibr" rid="B23">de Lecea et al., 1995</xref>; <xref ref-type="bibr" rid="B48">Huang et al., 1999</xref>), hippocampus (<xref ref-type="bibr" rid="B23">de Lecea et al., 1995</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2014</xref>), and cerebellar Pvalb neurons (<xref ref-type="bibr" rid="B20">Collin et al., 2005</xref>). In the reported cases adult levels were reached in the time window of PND24-28, coinciding with the electrophysiological maturation of GABAergic interneurons leveling off by the end of the 4th week of development (<xref ref-type="bibr" rid="B14">Chattopadhyaya et al., 2004</xref>; <xref ref-type="bibr" rid="B25">Doischer et al., 2008</xref>; <xref ref-type="bibr" rid="B71">Okaty et al., 2009</xref>). Yet, the precise trajectory of PV expression levels and of functional Pvalb neuron maturation in mouse SSC and mPFC are currently unknown. For a direct comparison of VPA mice explored in this study with previously investigated models such as Shank1<sup>-/-</sup>, Shank3B<sup>-/-</sup>, as well as PV<sup>+/-</sup> and PV<sup>-/-</sup> mice (<xref ref-type="bibr" rid="B33">Filice et al., 2016</xref>), the latter having also shown behavioral phenotypes with relevance to all ASD core symptoms at PND25 (<xref ref-type="bibr" rid="B98">Wohr et al., 2015</xref>), we selected this time point in our study. Of note, our forebrain lysates of PND25 mice that were used for quantification of RNA and protein levels provide a lower spatial resolution than our results obtained by stereological counts. Interestingly in PND70-80 mice having reached adult PV expression levels with certainty, no differences existed in SSC PV levels between VPA and control mice (<xref ref-type="bibr" rid="B49">Iijima et al., 2016</xref>).</p>
<p>Both, mRNA and protein levels of K<sub>v</sub>3.1b were significantly decreased in forebrain extracts of VPA mice as also reported for SSC recently (<xref ref-type="bibr" rid="B49">Iijima et al., 2016</xref>). In the mouse cortex, K<sub>v</sub>3.1b channels are exclusively expressed in Pvalb neurons (99% of all PV<sup>+</sup> neurons are K<sub>v</sub>3.1b<sup>+</sup> and <italic>vice versa</italic> (<xref ref-type="bibr" rid="B18">Chow et al., 1999</xref>)), where they are necessary for maintaining the fast-spiking phenotype of these neurons (<xref ref-type="bibr" rid="B18">Chow et al., 1999</xref>; <xref ref-type="bibr" rid="B46">Hernandez-Pineda et al., 1999</xref>; <xref ref-type="bibr" rid="B58">Lien and Jonas, 2003</xref>). The next closest relative, K<sub>v</sub>3.2, is also expressed in Pvalb neurons, but its distribution is more widespread. Not only is it expressed in other interneuron types, but also in cortical glutamatergic inputs from thalamo-cortical neurons (<xref ref-type="bibr" rid="B18">Chow et al., 1999</xref>). K<sub>v</sub>3 channels are voltage-gated K<sup>+</sup> channels involved in the rapid repolarization of the action potential (AP) mostly in fast-spiking neurons (<xref ref-type="bibr" rid="B58">Lien and Jonas, 2003</xref>). K<sub>v</sub>3.1 deficiency, or pharmacologically blocking K<sub>v</sub>3 channels, leads to broadening of AP duration due to a reduced rate of repolarization resulting in a potentiation of transmitter release (<xref ref-type="bibr" rid="B29">Erisir et al., 1999</xref>; <xref ref-type="bibr" rid="B78">Porcello et al., 2002</xref>; <xref ref-type="bibr" rid="B58">Lien and Jonas, 2003</xref>; <xref ref-type="bibr" rid="B51">Jonas et al., 2004</xref>; <xref ref-type="bibr" rid="B30">Espinosa et al., 2008</xref>). Resulting from the observed decrease of K<sub>v</sub>3.1b in Pvalb neurons leading to after-hyperpolarization (AHP) likely mediated by K<sub>v</sub>3.2 that are characterized by a 2-3 fold slower deactivation kinetics compared to K<sub>v</sub>3.1b, we hypothesize enhanced and likely kinetically slower GABA release from Pvalb neurons. Indeed, mIPSC kinetics in the temporal cortex of VPA rats are significantly slower with respect to both rise and decay times (<xref ref-type="bibr" rid="B3">Banerjee et al., 2013</xref>). Likely as a consequence of broadening of AP, fast-frequency firing is severely compromised in neurons from K<sub>v</sub>3.1<sup>-/-</sup> mice (<xref ref-type="bibr" rid="B29">Erisir et al., 1999</xref>; <xref ref-type="bibr" rid="B78">Porcello et al., 2002</xref>; <xref ref-type="bibr" rid="B58">Lien and Jonas, 2003</xref>). This in turn leads to alterations in oscillatory synchrony patterns, a function normally exerted by Pvalb neurons, resulting in a gamma dys-synchrony phenotype (<xref ref-type="bibr" rid="B50">Joho et al., 1999</xref>; <xref ref-type="bibr" rid="B78">Porcello et al., 2002</xref>), a feature often observed in ASD (<xref ref-type="bibr" rid="B91">Uhlhaas and Singer, 2007</xref>). Of note, reductions in gamma power are observed in hippocampal slices of PV<sup>-/-</sup> mice <italic>in vitro</italic> (<xref ref-type="bibr" rid="B94">Vreugdenhil et al., 2003</xref>), however, the effects of PV-deficiency on gamma oscillations in the cortex <italic>in vivo</italic> are unknown.</p>
<p>Expression of <italic>Pvalb, Hcn1</italic>, and <italic>Kcnc1</italic> genes are subject to activity/experience-dependent regulation mechanisms (<xref ref-type="bibr" rid="B32">Fan et al., 2005</xref>; <xref ref-type="bibr" rid="B39">Grabert and Wahle, 2009</xref>; <xref ref-type="bibr" rid="B6">Berridge, 2014</xref>). Consequently, the observed alterations in expression levels of PV, HCN1, and K<sub>v</sub>3.1 are likely the result of altered brain development and most probably altered neuronal signaling in VPA mice during early postnatal development. The modifications brought about by VPA are brain region-specific and include striatum, mPFC and SSC. However, at the functional level, there appears to exist a certain convergence. Both the decrease in PV in striatal Pvalb neurons, as well as the decrease in K<sub>v</sub>3.1b in forebrain Pvalb neurons might be viewed as homeostatic mechanisms to augment Pvalb neuron-mediated inhibition counteracting the hyper-connectivity and hyper-plasticity observed in mPFC pyramidal neurons (<xref ref-type="bibr" rid="B81">Rinaldi et al., 2008</xref>).</p>
<p>Interestingly, the decrease in cortical PV as well as K<sub>v</sub>3.1 expression observed in the SSC of young (PND15–PND21) VPA mice is no longer present in adult (PND70–PND90) mice (<xref ref-type="bibr" rid="B49">Iijima et al., 2016</xref>). This would fit to the concept of homeostatic plasticity, which suggests the presence of adaptive/homeostatic regulatory mechanisms in the brain that aim to maintain the stability and functionality of neural circuits when challenged by environmental (e.g., VPA) or other insults during development (<xref ref-type="bibr" rid="B90">Turrigiano, 2011</xref>). Such likely mechanisms are operational in HCN1<sup>-/-</sup> mice; the absence of HCN1 resulted in an increase in background GABA<sub>A</sub> currents by up-regulating GABA<sub>A</sub> α5 subunit expression (<xref ref-type="bibr" rid="B16">Chen et al., 2010</xref>). According to our study, such homeostatic mechanisms are brain region- and gene-specific in VPA mice. Further studies including functional experiments and moreover determination of expression profiles of, e.g., K<sub>v</sub>3.1b, HCN1 in more precisely defined brain regions (mPFC, SSC) need to be performed to confirm these hypotheses.</p>
<p>Serving as the input structure of the basal ganglia, the striatum receives a great number of sensory inputs and participates in regulating motor control, behavioral flexibility, motivational state, goal-directed learning, and attention. In particular, striatal dysfunction is assumed to underlie repetitive motor behaviors commonly seen in ASD (<xref ref-type="bibr" rid="B34">Fuccillo, 2016</xref>). Striatal PV downregulation has previously been described in PV<sup>+/-</sup> and Shank3B<sup>-/-</sup> mice (<xref ref-type="bibr" rid="B33">Filice et al., 2016</xref>) and both of these models show a robust ASD phenotype including repetitive or stereotyped patterns of behavior (<xref ref-type="bibr" rid="B75">Peca et al., 2011</xref>; <xref ref-type="bibr" rid="B98">Wohr et al., 2015</xref>). Moreover, alterations in striatal structure or function have been found in human ASD patients (<xref ref-type="bibr" rid="B57">Langen et al., 2007</xref>; <xref ref-type="bibr" rid="B31">Estes et al., 2011</xref>) and multiple ASD mouse model such as FMR1<sup>-/-</sup> (<xref ref-type="bibr" rid="B13">Centonze et al., 2008</xref>), Shank3<sup>-/-</sup> (<xref ref-type="bibr" rid="B75">Peca et al., 2011</xref>), CNTNAP2<sup>-/-</sup> (<xref ref-type="bibr" rid="B76">Penagarikano et al., 2011</xref>), CNTNAP4<sup>-/-</sup> (<xref ref-type="bibr" rid="B52">Karayannis et al., 2014</xref>), and VPA rats (<xref ref-type="bibr" rid="B85">Schneider et al., 2007</xref>). Taken together, striatal PV downregulation represents a promising cellular/morphological phenotype overlapping between different ASD models. It remains to be shown whether alterations in PV, HCN1 and K<sub>v</sub>3.1 are common to other ASD models and/or observed in human ASD subjects and whether they persist into adulthood. If confirmed, the three genes might represent attractive targets for novel therapeutic strategies in ASD.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>BS conceived the study, participated in the data analyses and in the writing of the manuscript. EL carried out the experiments, performed the statistical analysis and participated in writing of the manuscript. FF participated in setting up stereological experiments and writing of the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This study was supported by the Swiss National Science Foundation (SNF grant: 310030_155952/1 to BS).</p>
</fn>
</fn-group>
<ack>
<p>The authors wish to thank Simone Eichenberger and Martine Steinauer, University of Fribourg, for the maintenance of the mouse facility and technical assistance, respectively.</p>
</ack>
<sec sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fnmol.2016.00150/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fnmol.2016.00150/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Data_Sheet_1.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcantara</surname><given-names>S.</given-names></name><name><surname>Ferrer</surname><given-names>I.</given-names></name><name><surname>Soriano</surname><given-names>E.</given-names></name></person-group> (<year>1993</year>). <article-title>Postnatal development of parvalbumin and calbindin D28K immunoreactivities in the cerebral cortex of the rat.</article-title>
<source/><italic>Anat. Embryol.</italic>
<volume>188</volume>
<fpage>63</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/BF00191452</pub-id><pub-id pub-id-type="pmid">8214625</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="book"><collab>American Psychiatric Association</collab> (<year>2013</year>). <source/><italic>Diagnostic and Statistical Manual of Mental Disorders: DSM-5</italic>.
<publisher-loc>Arlington, VA</publisher-loc>: <publisher-name>American Psychiatric Publishing</publisher-name>.</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>A.</given-names></name><name><surname>Garcia-Oscos</surname><given-names>F.</given-names></name><name><surname>Roychowdhury</surname><given-names>S.</given-names></name><name><surname>Galindo</surname><given-names>L. C.</given-names></name><name><surname>Hall</surname><given-names>S.</given-names></name><name><surname>Kilgard</surname><given-names>M. P.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism.</article-title>
<source/><italic>Int. J. Neuropsychopharmacol.</italic>
<volume>16</volume>
<fpage>1309</fpage>–<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145712001216</pub-id><pub-id pub-id-type="pmid">23228615</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartos</surname><given-names>M.</given-names></name><name><surname>Vida</surname><given-names>I.</given-names></name><name><surname>Frotscher</surname><given-names>M.</given-names></name><name><surname>Meyer</surname><given-names>A.</given-names></name><name><surname>Monyer</surname><given-names>H.</given-names></name><name><surname>Geiger</surname><given-names>J. R.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Fast synaptic inhibition promotes synchronized gamma oscillations in hippocampal interneuron networks.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>99</volume>
<fpage>13222</fpage>–<lpage>13227</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.192233099</pub-id><pub-id pub-id-type="pmid">12235359</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benarroch</surname><given-names>E. E.</given-names></name></person-group> (<year>2013</year>). <article-title>HCN channels: function and clinical implications.</article-title>
<source/><italic>Neurology</italic>
<volume>80</volume>
<fpage>304</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e31827dec42</pub-id><pub-id pub-id-type="pmid">23319474</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>M. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia.</article-title>
<source/><italic>Cell Tissue Res.</italic>
<volume>357</volume>
<fpage>477</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-014-1806-z</pub-id><pub-id pub-id-type="pmid">24577622</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biel</surname><given-names>M.</given-names></name><name><surname>Wahl-Schott</surname><given-names>C.</given-names></name><name><surname>Michalakis</surname><given-names>S.</given-names></name><name><surname>Zong</surname><given-names>X.</given-names></name></person-group> (<year>2009</year>). <article-title>Hyperpolarization-activated cation channels: from genes to function.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>89</volume>
<fpage>847</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00029.2008</pub-id><pub-id pub-id-type="pmid">19584315</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bromley</surname><given-names>R. L.</given-names></name><name><surname>Mawer</surname><given-names>G. E.</given-names></name><name><surname>Briggs</surname><given-names>M.</given-names></name><name><surname>Cheyne</surname><given-names>C.</given-names></name><name><surname>Clayton-Smith</surname><given-names>J.</given-names></name><name><surname>Garcia-Finana</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs.</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatry</italic>
<volume>84</volume>
<fpage>637</fpage>–<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2012-304270</pub-id><pub-id pub-id-type="pmid">23370617</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buzsaki</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>X. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Mechanisms of gamma oscillations.</article-title>
<source/><italic>Annu. Rev. Neurosci.</italic>
<volume>35</volume>
<fpage>203</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-062111-150444</pub-id><pub-id pub-id-type="pmid">22443509</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cain</surname><given-names>S. M.</given-names></name><name><surname>Tyson</surname><given-names>J. R.</given-names></name><name><surname>Jones</surname><given-names>K. L.</given-names></name><name><surname>Snutch</surname><given-names>T. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Thalamocortical neurons display suppressed burst-firing due to an enhanced Ih current in a genetic model of absence epilepsy.</article-title>
<source/><italic>Pflugers Arch.</italic>
<volume>467</volume>
<fpage>1367</fpage>–<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-014-1549-4</pub-id><pub-id pub-id-type="pmid">24953239</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celio</surname><given-names>M. R.</given-names></name></person-group> (<year>1990</year>). <article-title>Calbindin D-28k and parvalbumin in the rat nervous system.</article-title>
<source/><italic>Neuroscience</italic>
<volume>35</volume>
<fpage>375</fpage>–<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(90)90091-H</pub-id><pub-id pub-id-type="pmid">2199841</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celio</surname><given-names>M. R.</given-names></name><name><surname>Heizmann</surname><given-names>C. W.</given-names></name></person-group> (<year>1981</year>). <article-title>Calcium-binding protein parvalbumin as a neuronal marker.</article-title>
<source/><italic>Nature</italic>
<volume>293</volume>
<fpage>300</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1038/293300a0</pub-id><pub-id pub-id-type="pmid">7278987</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Centonze</surname><given-names>D.</given-names></name><name><surname>Rossi</surname><given-names>S.</given-names></name><name><surname>Mercaldo</surname><given-names>V.</given-names></name><name><surname>Napoli</surname><given-names>I.</given-names></name><name><surname>Ciotti</surname><given-names>M. T.</given-names></name><name><surname>De Chiara</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>63</volume>
<fpage>963</fpage>–<lpage>973</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2007.09.008</pub-id><pub-id pub-id-type="pmid">18028882</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyaya</surname><given-names>B.</given-names></name><name><surname>Di Cristo</surname><given-names>G.</given-names></name><name><surname>Higashiyama</surname><given-names>H.</given-names></name><name><surname>Knott</surname><given-names>G. W.</given-names></name><name><surname>Kuhlman</surname><given-names>S. J.</given-names></name><name><surname>Welker</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Experience and activity-dependent maturation of perisomatic GABAergic innervation in primary visual cortex during a postnatal critical period.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>9598</fpage>–<lpage>9611</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1851-04.2004</pub-id><pub-id pub-id-type="pmid">15509747</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Perez</surname><given-names>S. M.</given-names></name><name><surname>Lodge</surname><given-names>D. J.</given-names></name></person-group> (<year>2014</year>). <article-title>An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.</article-title>
<source/><italic>Dev. Neurobiol.</italic>
<volume>74</volume>
<fpage>907</fpage>–<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22172</pub-id><pub-id pub-id-type="pmid">24554310</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Shu</surname><given-names>S.</given-names></name><name><surname>Schwartz</surname><given-names>L. C.</given-names></name><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Kapur</surname><given-names>J.</given-names></name><name><surname>Bayliss</surname><given-names>D. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Homeostatic regulation of synaptic excitability: tonic GABA(A) receptor currents replace I(h) in cortical pyramidal neurons of HCN1 knock-out mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>2611</fpage>–<lpage>2622</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3771-09.2010</pub-id><pub-id pub-id-type="pmid">20164346</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>R. Y.</given-names></name><name><surname>Konecky</surname><given-names>R. O.</given-names></name><name><surname>Carter</surname><given-names>C. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>19878</fpage>–<lpage>19883</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0609440103</pub-id><pub-id pub-id-type="pmid">17170134</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>A.</given-names></name><name><surname>Erisir</surname><given-names>A.</given-names></name><name><surname>Farb</surname><given-names>C.</given-names></name><name><surname>Nadal</surname><given-names>M. S.</given-names></name><name><surname>Ozaita</surname><given-names>A.</given-names></name><name><surname>Lau</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>K(+) channel expression distinguishes subpopulations of parvalbumin- and somatostatin-containing neocortical interneurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>19</volume>
<fpage>9332</fpage>–<lpage>9345</lpage>.<pub-id pub-id-type="pmid">10531438</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>J.</given-names></name><name><surname>Gronborg</surname><given-names>T. K.</given-names></name><name><surname>Sorensen</surname><given-names>M. J.</given-names></name><name><surname>Schendel</surname><given-names>D.</given-names></name><name><surname>Parner</surname><given-names>E. T.</given-names></name><name><surname>Pedersen</surname><given-names>L. H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.</article-title>
<source/><italic>JAMA</italic>
<volume>309</volume>
<fpage>1696</fpage>–<lpage>1703</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2013.2270</pub-id><pub-id pub-id-type="pmid">23613074</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collin</surname><given-names>T.</given-names></name><name><surname>Chat</surname><given-names>M.</given-names></name><name><surname>Lucas</surname><given-names>M. G.</given-names></name><name><surname>Moreno</surname><given-names>H.</given-names></name><name><surname>Racay</surname><given-names>P.</given-names></name><name><surname>Schwaller</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Developmental changes in parvalbumin regulate presynaptic Ca2+ signaling.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>96</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3748-04.2005</pub-id><pub-id pub-id-type="pmid">15634771</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courchesne</surname><given-names>E.</given-names></name><name><surname>Campbell</surname><given-names>K.</given-names></name><name><surname>Solso</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Brain growth across the life span in autism: age-specific changes in anatomical pathology.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1380</volume>
<fpage>138</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.101</pub-id><pub-id pub-id-type="pmid">20920490</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Torre-Ubieta</surname><given-names>L.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Stein</surname><given-names>J. L.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Advancing the understanding of autism disease mechanisms through genetics.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>22</volume>
<fpage>345</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4071</pub-id><pub-id pub-id-type="pmid">27050589</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lecea</surname><given-names>L.</given-names></name><name><surname>del Rio</surname><given-names>J. A.</given-names></name><name><surname>Soriano</surname><given-names>E.</given-names></name></person-group> (<year>1995</year>). <article-title>Developmental expression of parvalbumin mRNA in the cerebral cortex and hippocampus of the rat.</article-title>
<source/><italic>Brain Res. Mol. Brain Res.</italic>
<volume>32</volume>
<fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/0169-328X(95)00056-X</pub-id><pub-id pub-id-type="pmid">7494447</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dendrinos</surname><given-names>G.</given-names></name><name><surname>Hemelt</surname><given-names>M.</given-names></name><name><surname>Keller</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Prenatal VPA exposure and changes in sensory processing by the superior colliculus.</article-title>
<source/><italic>Front. Integr. Neurosci.</italic>
<volume>5</volume>:<issue>68</issue>
<pub-id pub-id-type="doi">10.3389/fnint.2011.00068</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doischer</surname><given-names>D.</given-names></name><name><surname>Hosp</surname><given-names>J. A.</given-names></name><name><surname>Yanagawa</surname><given-names>Y.</given-names></name><name><surname>Obata</surname><given-names>K.</given-names></name><name><surname>Jonas</surname><given-names>P.</given-names></name><name><surname>Vida</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Postnatal differentiation of basket cells from slow to fast signaling devices.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>12956</fpage>–<lpage>12968</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2890-08.2008</pub-id><pub-id pub-id-type="pmid">19036989</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eickholt</surname><given-names>B. J.</given-names></name><name><surname>Towers</surname><given-names>G. J.</given-names></name><name><surname>Ryves</surname><given-names>W. J.</given-names></name><name><surname>Eikel</surname><given-names>D.</given-names></name><name><surname>Adley</surname><given-names>K.</given-names></name><name><surname>Ylinen</surname><given-names>L. M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure.</article-title>
<source/><italic>Mol. Pharmacol.</italic>
<volume>67</volume>
<fpage>1426</fpage>–<lpage>1433</lpage>. <pub-id pub-id-type="doi">10.1124/mol.104.009308</pub-id><pub-id pub-id-type="pmid">15687223</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellegood</surname><given-names>J.</given-names></name><name><surname>Anagnostou</surname><given-names>E.</given-names></name><name><surname>Babineau</surname><given-names>B. A.</given-names></name><name><surname>Crawley</surname><given-names>J. N.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Genestine</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>20</volume>
<fpage>118</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.98</pub-id><pub-id pub-id-type="pmid">25199916</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ergaz</surname><given-names>Z.</given-names></name><name><surname>Weinstein-Fudim</surname><given-names>L.</given-names></name><name><surname>Ornoy</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic and non-genetic animal models for autism spectrum disorders (ASD).</article-title>
<source/><italic>Reprod. Toxicol.</italic>
<volume>64</volume>
<fpage>116</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2016.04.024</pub-id><pub-id pub-id-type="pmid">27142188</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erisir</surname><given-names>A.</given-names></name><name><surname>Lau</surname><given-names>D.</given-names></name><name><surname>Rudy</surname><given-names>B.</given-names></name><name><surname>Leonard</surname><given-names>C. S.</given-names></name></person-group> (<year>1999</year>). <article-title>Function of specific K(+) channels in sustained high-frequency firing of fast-spiking neocortical interneurons.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>82</volume>
<fpage>2476</fpage>–<lpage>2489</lpage>.<pub-id pub-id-type="pmid">10561420</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinosa</surname><given-names>F.</given-names></name><name><surname>Torres-Vega</surname><given-names>M. A.</given-names></name><name><surname>Marks</surname><given-names>G. A.</given-names></name><name><surname>Joho</surname><given-names>R. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Ablation of Kv3.1 and <italic>Kv</italic>3.3 potassium channels disrupts thalamocortical oscillations in vitro and in vivo.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>5570</fpage>–<lpage>5581</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0747-08.2008</pub-id><pub-id pub-id-type="pmid">18495891</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estes</surname><given-names>A.</given-names></name><name><surname>Shaw</surname><given-names>D. W.</given-names></name><name><surname>Sparks</surname><given-names>B. F.</given-names></name><name><surname>Friedman</surname><given-names>S.</given-names></name><name><surname>Giedd</surname><given-names>J. N.</given-names></name><name><surname>Dawson</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Basal ganglia morphometry and repetitive behavior in young children with autism spectrum disorder.</article-title>
<source/><italic>Autism Res.</italic>
<volume>4</volume>
<fpage>212</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1002/aur.193</pub-id><pub-id pub-id-type="pmid">21480545</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y.</given-names></name><name><surname>Fricker</surname><given-names>D.</given-names></name><name><surname>Brager</surname><given-names>D. H.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>H. C.</given-names></name><name><surname>Chitwood</surname><given-names>R. A.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Activity-dependent decrease of excitability in rat hippocampal neurons through increases in I(h).</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>8</volume>
<fpage>1542</fpage>–<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.1038/nn1568</pub-id><pub-id pub-id-type="pmid">16234810</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filice</surname><given-names>F.</given-names></name><name><surname>Vorckel</surname><given-names>K. J.</given-names></name><name><surname>Sungur</surname><given-names>A. O.</given-names></name><name><surname>Wohr</surname><given-names>M.</given-names></name><name><surname>Schwaller</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism.</article-title>
<source/><italic>Mol. Brain</italic>
<volume>9</volume>: <issue>10</issue>
<pub-id pub-id-type="doi">10.1186/s13041-016-0192-8</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuccillo</surname><given-names>M. V.</given-names></name></person-group> (<year>2016</year>). <article-title>Striatal circuits as a common node for autism pathophysiology.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>10</volume>:<issue>27</issue>
<pub-id pub-id-type="doi">10.3389/fnins.2016.00027</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgiev</surname><given-names>D.</given-names></name><name><surname>Gonzalez-Burgos</surname><given-names>G.</given-names></name><name><surname>Kikuchi</surname><given-names>M.</given-names></name><name><surname>Minabe</surname><given-names>Y.</given-names></name><name><surname>Lewis</surname><given-names>D. A.</given-names></name><name><surname>Hashimoto</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Selective expression of KCNS3 potassium channel alpha-subunit in parvalbumin-containing GABA neurons in the human prefrontal cortex.</article-title>
<source/><italic>PLoS ONE</italic>
<volume>7</volume>:<issue>e43904</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0043904</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>H. S.</given-names></name><name><surname>Kim</surname><given-names>K. C.</given-names></name><name><surname>Choi</surname><given-names>C. S.</given-names></name><name><surname>Jeon</surname><given-names>S. J.</given-names></name><name><surname>Kwon</surname><given-names>K. J.</given-names></name><name><surname>Han</surname><given-names>S. H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3beta/beta-catenin pathway.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>63</volume>
<fpage>1028</fpage>–<lpage>1041</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.07.028</pub-id><pub-id pub-id-type="pmid">22841957</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogolla</surname><given-names>N.</given-names></name><name><surname>Leblanc</surname><given-names>J. J.</given-names></name><name><surname>Quast</surname><given-names>K. B.</given-names></name><name><surname>Sudhof</surname><given-names>T. C.</given-names></name><name><surname>Fagiolini</surname><given-names>M.</given-names></name><name><surname>Hensch</surname><given-names>T. K.</given-names></name></person-group> (<year>2009</year>). <article-title>Common circuit defect of excitatory-inhibitory balance in mouse models of autism.</article-title>
<source/><italic>J. Neurodev. Disord.</italic>
<volume>1</volume>
<fpage>172</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1007/s11689-009-9023-x</pub-id><pub-id pub-id-type="pmid">20664807</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gottfried</surname><given-names>C.</given-names></name><name><surname>Bambini-Junior</surname><given-names>V.</given-names></name><name><surname>Baronio</surname><given-names>D.</given-names></name><name><surname>Zanatta</surname><given-names>G.</given-names></name><name><surname>Bristot</surname><given-names>R.</given-names></name><name><surname>Vaccaro</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>“Valproic acid in autism spectrum disorder: from an environmental risk factor to a reliable animal model,” in</article-title>
<source/><italic>Recent Advances in Autism Spectrum Disorders</italic>
<volume>Vol. I</volume>
<role>ed.</role>
<person-group person-group-type="editor"><name><surname>Fitzgeral</surname><given-names>M.</given-names></name></person-group> (<publisher-loc>Rijeka</publisher-loc>: <publisher-name>InTech</publisher-name>).</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabert</surname><given-names>J.</given-names></name><name><surname>Wahle</surname><given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Visual experience regulates Kv3.1<italic>b and Kv</italic>3.2 expression in developing rat visual cortex.</article-title>
<source/><italic>Neuroscience</italic>
<volume>158</volume>
<fpage>654</fpage>–<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.07.035</pub-id><pub-id pub-id-type="pmid">18708127</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gundersen</surname><given-names>H. J.</given-names></name><name><surname>Bendtsen</surname><given-names>T. F.</given-names></name><name><surname>Korbo</surname><given-names>L.</given-names></name><name><surname>Marcussen</surname><given-names>N.</given-names></name><name><surname>Moller</surname><given-names>A.</given-names></name><name><surname>Nielsen</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>1988</year>). <article-title>Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.</article-title>
<source/><italic>APMIS</italic>
<volume>96</volume>
<fpage>379</fpage>–<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1111/j.1699-0463.1988.tb00954.x</pub-id><pub-id pub-id-type="pmid">3288247</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gundersen</surname><given-names>H. J.</given-names></name><name><surname>Jensen</surname><given-names>E. B.</given-names></name><name><surname>Kieu</surname><given-names>K.</given-names></name><name><surname>Nielsen</surname><given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>The efficiency of systematic sampling in stereology–reconsidered.</article-title>
<source/><italic>J. Micros.</italic>
<volume>193</volume>
<fpage>199</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2818.1999.00457.x</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haddad</surname><given-names>P. M.</given-names></name><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Ashfaq</surname><given-names>M.</given-names></name><name><surname>Wieck</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>A review of valproate in psychiatric practice.</article-title>
<source/><italic>Expert Opin. Drug Metab. Toxicol.</italic>
<volume>5</volume>
<fpage>539</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1517/17425250902911455</pub-id><pub-id pub-id-type="pmid">19409030</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartig</surname><given-names>W.</given-names></name><name><surname>Brauer</surname><given-names>K.</given-names></name><name><surname>Bruckner</surname><given-names>G.</given-names></name></person-group> (<year>1992</year>). <article-title>Wisteria floribunda agglutinin-labelled nets surround parvalbumin-containing neurons.</article-title>
<source/><italic>Neuroreport</italic>
<volume>3</volume>
<fpage>869</fpage>–<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199210000-00012</pub-id><pub-id pub-id-type="pmid">1421090</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>E.</given-names></name><name><surname>Ariza</surname><given-names>J.</given-names></name><name><surname>Rogers</surname><given-names>H.</given-names></name><name><surname>Noctor</surname><given-names>S. C.</given-names></name><name><surname>Martinez-Cerdeno</surname><given-names>V.</given-names></name></person-group> (<year>2016</year>). <article-title>The number of parvalbumin-expressing interneurons is decreased in the medial prefrontal cortex in autism.</article-title>
<source/><italic>Cerebral cortex</italic>
<pub-id pub-id-type="doi">10.1093/cercor/bhw021</pub-id>
<comment>[Epub ahead of print]</comment></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haunso</surname><given-names>A.</given-names></name><name><surname>Ibrahim</surname><given-names>M.</given-names></name><name><surname>Bartsch</surname><given-names>U.</given-names></name><name><surname>Letiembre</surname><given-names>M.</given-names></name><name><surname>Celio</surname><given-names>M. R.</given-names></name><name><surname>Menoud</surname><given-names>P.</given-names></name></person-group> (<year>2000</year>). <article-title>Morphology of perineuronal nets in tenascin-R and parvalbumin single and double knockout mice.</article-title>
<source/><italic>Brain Res.</italic>
<volume>864</volume>
<fpage>142</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(00)02173-9</pub-id><pub-id pub-id-type="pmid">10793198</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Pineda</surname><given-names>R.</given-names></name><name><surname>Chow</surname><given-names>A.</given-names></name><name><surname>Amarillo</surname><given-names>Y.</given-names></name><name><surname>Moreno</surname><given-names>H.</given-names></name><name><surname>Saganich</surname><given-names>M.</given-names></name><name><surname>Vega-Saenz de Miera</surname><given-names>E. C.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Kv3.1<italic>-Kv</italic>3.2 channels underlie a high-voltage-activating component of the delayed rectifier K+ current in projecting neurons from the globus pallidus.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>82</volume>
<fpage>1512</fpage>–<lpage>1528</lpage>.<pub-id pub-id-type="pmid">10482766</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Walker</surname><given-names>M. C.</given-names></name><name><surname>Shah</surname><given-names>M. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Loss of dendritic HCN1 subunits enhances cortical excitability and epileptogenesis.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>10979</fpage>–<lpage>10988</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1531-09.2009</pub-id><pub-id pub-id-type="pmid">19726656</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z. J.</given-names></name><name><surname>Kirkwood</surname><given-names>A.</given-names></name><name><surname>Pizzorusso</surname><given-names>T.</given-names></name><name><surname>Porciatti</surname><given-names>V.</given-names></name><name><surname>Morales</surname><given-names>B.</given-names></name><name><surname>Bear</surname><given-names>M. F.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex.</article-title>
<source/><italic>Cell</italic>
<volume>98</volume>
<fpage>739</fpage>–<lpage>755</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81509-3</pub-id><pub-id pub-id-type="pmid">10499792</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iijima</surname><given-names>Y.</given-names></name><name><surname>Behr</surname><given-names>K.</given-names></name><name><surname>Iijima</surname><given-names>T.</given-names></name><name><surname>Biemans</surname><given-names>B.</given-names></name><name><surname>Bischofberger</surname><given-names>J.</given-names></name><name><surname>Scheiffele</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Distinct defects in synaptic differentiation of neocortical neurons in response to prenatal valproate exposure.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>: <issue>27400</issue>
<pub-id pub-id-type="doi">10.1038/srep27400</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joho</surname><given-names>R. H.</given-names></name><name><surname>Ho</surname><given-names>C. S.</given-names></name><name><surname>Marks</surname><given-names>G. A.</given-names></name></person-group> (<year>1999</year>). <article-title>Increased gamma- and decreased delta-oscillations in a mouse deficient for a potassium channel expressed in fast-spiking interneurons.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>82</volume>
<fpage>1855</fpage>–<lpage>1864</lpage>.<pub-id pub-id-type="pmid">10515974</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>P.</given-names></name><name><surname>Bischofberger</surname><given-names>J.</given-names></name><name><surname>Fricker</surname><given-names>D.</given-names></name><name><surname>Miles</surname><given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>Interneuron diversity series: fast in, fast out–temporal and spatial signal processing in hippocampal interneurons.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>27</volume>
<fpage>30</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2003.10.010</pub-id><pub-id pub-id-type="pmid">14698608</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karayannis</surname><given-names>T.</given-names></name><name><surname>Au</surname><given-names>E.</given-names></name><name><surname>Patel</surname><given-names>J. C.</given-names></name><name><surname>Kruglikov</surname><given-names>I.</given-names></name><name><surname>Markx</surname><given-names>S.</given-names></name><name><surname>Delorme</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission.</article-title>
<source/><italic>Nature</italic>
<volume>511</volume>
<fpage>236</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1038/nature13248</pub-id><pub-id pub-id-type="pmid">24870235</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>S.</given-names></name><name><surname>Takuma</surname><given-names>K.</given-names></name><name><surname>Hara</surname><given-names>Y.</given-names></name><name><surname>Maeda</surname><given-names>Y.</given-names></name><name><surname>Ago</surname><given-names>Y.</given-names></name><name><surname>Matsuda</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid.</article-title>
<source/><italic>Int. J. Neuropsychopharmacol.</italic>
<volume>16</volume>
<fpage>91</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145711001714</pub-id><pub-id pub-id-type="pmid">22093185</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>S.</given-names></name><name><surname>Hashmi</surname><given-names>J. A.</given-names></name><name><surname>Mamashli</surname><given-names>F.</given-names></name><name><surname>Bharadwaj</surname><given-names>H. M.</given-names></name><name><surname>Ganesan</surname><given-names>S.</given-names></name><name><surname>Michmizos</surname><given-names>K. P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Altered onset response dynamics in somatosensory processing in autism spectrum disorder.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>10</volume>:<issue>255</issue>
<pub-id pub-id-type="doi">10.3389/fnins.2016.00255</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleijer</surname><given-names>K. T.</given-names></name><name><surname>Schmeisser</surname><given-names>M. J.</given-names></name><name><surname>Krueger</surname><given-names>D. D.</given-names></name><name><surname>Boeckers</surname><given-names>T. M.</given-names></name><name><surname>Scheiffele</surname><given-names>P.</given-names></name><name><surname>Bourgeron</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Neurobiology of autism gene products: towards pathogenesis and drug targets.</article-title>
<source/><italic>Psychopharmacology</italic>
<volume>231</volume>
<fpage>1037</fpage>–<lpage>1062</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-013-3403-3</pub-id><pub-id pub-id-type="pmid">24419271</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuisle</surname><given-names>M.</given-names></name><name><surname>Wanaverbecq</surname><given-names>N.</given-names></name><name><surname>Brewster</surname><given-names>A. L.</given-names></name><name><surname>Frere</surname><given-names>S. G.</given-names></name><name><surname>Pinault</surname><given-names>D.</given-names></name><name><surname>Baram</surname><given-names>T. Z.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Functional stabilization of weakened thalamic pacemaker channel regulation in rat absence epilepsy.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>575</volume>
<fpage>83</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2006.110486</pub-id><pub-id pub-id-type="pmid">16728450</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langen</surname><given-names>M.</given-names></name><name><surname>Durston</surname><given-names>S.</given-names></name><name><surname>Staal</surname><given-names>W. G.</given-names></name><name><surname>Palmen</surname><given-names>S. J.</given-names></name><name><surname>van Engeland</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>62</volume>
<fpage>262</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.09.040</pub-id><pub-id pub-id-type="pmid">17224135</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lien</surname><given-names>C.-C.</given-names></name><name><surname>Jonas</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Kv3 potassium conductance is necessary and kinetically optimized for high-frequency action potential generation in hippocampal interneurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>23</volume>
<fpage>2058</fpage>–<lpage>2068</lpage>.<pub-id pub-id-type="pmid">12657664</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>K. J.</given-names></name><name><surname>Schmittgen</surname><given-names>T. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method.</article-title>
<source/><italic>Methods</italic>
<volume>25</volume>
<fpage>402</fpage>–<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorincz</surname><given-names>A.</given-names></name><name><surname>Notomi</surname><given-names>T.</given-names></name><name><surname>Tamas</surname><given-names>G.</given-names></name><name><surname>Shigemoto</surname><given-names>R.</given-names></name><name><surname>Nusser</surname><given-names>Z.</given-names></name></person-group> (<year>2002</year>). <article-title>Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>5</volume>
<fpage>1185</fpage>–<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.1038/nn962</pub-id><pub-id pub-id-type="pmid">12389030</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loscher</surname><given-names>W.</given-names></name></person-group> (<year>1999</year>). <article-title>Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>58</volume>
<fpage>31</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/S0301-0082(98)00075-6</pub-id><pub-id pub-id-type="pmid">10321796</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukose</surname><given-names>R.</given-names></name><name><surname>Schmidt</surname><given-names>E.</given-names></name><name><surname>Wolski</surname><given-names>TP</given-names><suffix>Jr</suffix></name><name><surname>Murawski</surname><given-names>N. J.</given-names></name><name><surname>Kulesza</surname><given-names>RJ</given-names><suffix>Jr</suffix></name></person-group> (<year>2011</year>). <article-title>Malformation of the superior olivary complex in an animal model of autism.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1398</volume>
<fpage>102</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2011.05.013</pub-id><pub-id pub-id-type="pmid">21636076</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mabunga</surname><given-names>D. F.</given-names></name><name><surname>Gonzales</surname><given-names>E. L.</given-names></name><name><surname>Kim</surname><given-names>J. W.</given-names></name><name><surname>Kim</surname><given-names>K. C.</given-names></name><name><surname>Shin</surname><given-names>C. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Exploring the validity of valproic acid animal model of autism.</article-title>
<source/><italic>Exp. Neurobiol.</italic>
<volume>24</volume>
<fpage>285</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.5607/en.2015.24.4.285</pub-id><pub-id pub-id-type="pmid">26713077</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maetzler</surname><given-names>W.</given-names></name><name><surname>Stunitz</surname><given-names>H.</given-names></name><name><surname>Bendfeldt</surname><given-names>K.</given-names></name><name><surname>Vollenweider</surname><given-names>F.</given-names></name><name><surname>Schwaller</surname><given-names>B.</given-names></name><name><surname>Nitsch</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Microcalcification after excitotoxicity is enhanced in transgenic mice expressing parvalbumin in all neurones, may commence in neuronal mitochondria and undergoes structural modifications over time.</article-title>
<source/><italic>Neuropathol. Appl. Neurobiol.</italic>
<volume>35</volume>
<fpage>165</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2990.2008.00970.x</pub-id><pub-id pub-id-type="pmid">19284478</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markram</surname><given-names>K.</given-names></name><name><surname>Markram</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>The intense world theory – a unifying theory of the neurobiology of autism.</article-title>
<source/><italic>Front. Hum. Neurosci.</italic>
<volume>4</volume>:<issue>224</issue>
<pub-id pub-id-type="doi">10.3389/fnhum.2010.00224</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markram</surname><given-names>K.</given-names></name><name><surname>Rinaldi</surname><given-names>T.</given-names></name><name><surname>La Mendola</surname><given-names>D.</given-names></name><name><surname>Sandi</surname><given-names>C.</given-names></name><name><surname>Markram</surname><given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Abnormal fear conditioning and amygdala processing in an animal model of autism.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>33</volume>
<fpage>901</fpage>–<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1301453</pub-id><pub-id pub-id-type="pmid">17507914</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Sanchis</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Neurobiological foundations of multisensory integration in people with autism spectrum disorders: the role of the medial prefrontal cortex.</article-title>
<source/><italic>Front. Hum. Neurosci.</italic>
<volume>8</volume>:<issue>970</issue>
<pub-id pub-id-type="doi">10.3389/fnhum.2014.00970</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>A. H.</given-names></name><name><surname>Katona</surname><given-names>I.</given-names></name><name><surname>Blatow</surname><given-names>M.</given-names></name><name><surname>Rozov</surname><given-names>A.</given-names></name><name><surname>Monyer</surname><given-names>H.</given-names></name></person-group> (<year>2002</year>). <article-title>In vivo labeling of parvalbumin-positive interneurons and analysis of electrical coupling in identified neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>22</volume>
<fpage>7055</fpage>–<lpage>7064</lpage>.<pub-id pub-id-type="pmid">12177202</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moosmang</surname><given-names>S.</given-names></name><name><surname>Biel</surname><given-names>M.</given-names></name><name><surname>Hofmann</surname><given-names>F.</given-names></name><name><surname>Ludwig</surname><given-names>A.</given-names></name></person-group> (<year>1999</year>). <article-title>Differential distribution of four hyperpolarization-activated cation channels in mouse brain.</article-title>
<source/><italic>Biol. Chem.</italic>
<volume>380</volume>
<fpage>975</fpage>–<lpage>980</lpage>. <pub-id pub-id-type="doi">10.1515/BC.1999.121</pub-id><pub-id pub-id-type="pmid">10494850</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>N. P.</given-names></name><name><surname>Fyffe</surname><given-names>R. E.</given-names></name><name><surname>Robertson</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>Characterisation of hyperpolarization-activated currents (I(h)) in the medial septum/diagonal band complex in the mouse.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1006</volume>
<fpage>74</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2004.01.062</pub-id><pub-id pub-id-type="pmid">15047026</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okaty</surname><given-names>B. W.</given-names></name><name><surname>Miller</surname><given-names>M. N.</given-names></name><name><surname>Sugino</surname><given-names>K.</given-names></name><name><surname>Hempel</surname><given-names>C. M.</given-names></name><name><surname>Nelson</surname><given-names>S. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Transcriptional and electrophysiological maturation of neocortical fast-spiking GABAergic interneurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>7040</fpage>–<lpage>7052</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0105-09.2009</pub-id><pub-id pub-id-type="pmid">19474331</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orduz</surname><given-names>D.</given-names></name><name><surname>Bischop</surname><given-names>D. P.</given-names></name><name><surname>Schwaller</surname><given-names>B.</given-names></name><name><surname>Schiffmann</surname><given-names>S. N.</given-names></name><name><surname>Gall</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Parvalbumin tunes spike-timing and efferent short-term plasticity in striatal fast spiking interneurons.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>591</volume>
<fpage>3215</fpage>–<lpage>3232</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2012.250795</pub-id><pub-id pub-id-type="pmid">23551945</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ornoy</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Valproic acid in pregnancy: how much are we endangering the embryo and fetus?</article-title>
<source/><italic>Reprod. Toxicol.</italic>
<volume>28</volume>
<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2009.02.014</pub-id><pub-id pub-id-type="pmid">19490988</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G.</given-names></name></person-group> (<year>2001</year>). <source/><italic>The Mouse Brain in Stereotaxis Coordinates</italic>
<edition>2nd Edn.</edition>
<publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peca</surname><given-names>J.</given-names></name><name><surname>Feliciano</surname><given-names>C.</given-names></name><name><surname>Ting</surname><given-names>J. T.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Wells</surname><given-names>M. F.</given-names></name><name><surname>Venkatraman</surname><given-names>T. N.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction.</article-title>
<source/><italic>Nature</italic>
<volume>472</volume>
<fpage>437</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1038/nature09965</pub-id><pub-id pub-id-type="pmid">21423165</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penagarikano</surname><given-names>O.</given-names></name><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Herman</surname><given-names>E. I.</given-names></name><name><surname>Winden</surname><given-names>K. D.</given-names></name><name><surname>Gdalyahu</surname><given-names>A.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits.</article-title>
<source/><italic>Cell</italic>
<volume>147</volume>
<fpage>235</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.08.040</pub-id><pub-id pub-id-type="pmid">21962519</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phiel</surname><given-names>C. J.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Huang</surname><given-names>E. Y.</given-names></name><name><surname>Guenther</surname><given-names>M. G.</given-names></name><name><surname>Lazar</surname><given-names>M. A.</given-names></name><name><surname>Klein</surname><given-names>P. S.</given-names></name></person-group> (<year>2001</year>). <article-title>Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>276</volume>
<fpage>36734</fpage>–<lpage>36741</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M101287200</pub-id><pub-id pub-id-type="pmid">11473107</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porcello</surname><given-names>D. M.</given-names></name><name><surname>Ho</surname><given-names>C. S.</given-names></name><name><surname>Joho</surname><given-names>R. H.</given-names></name><name><surname>Huguenard</surname><given-names>J. R.</given-names></name></person-group> (<year>2002</year>). <article-title>Resilient RTN fast spiking in Kv3.1 null mice suggests redundancy in the action potential repolarization mechanism.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>87</volume>
<fpage>1303</fpage>–<lpage>1310</lpage>.<pub-id pub-id-type="pmid">11877504</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Racay</surname><given-names>P.</given-names></name><name><surname>Gregory</surname><given-names>P.</given-names></name><name><surname>Schwaller</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>Parvalbumin deficiency in fast-twitch muscles leads to increased ‘slow-twitch type’ mitochondria, but does not affect the expression of fiber specific proteins.</article-title>
<source/><italic>FEBS J.</italic>
<volume>273</volume>
<fpage>96</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2005.05046.x</pub-id><pub-id pub-id-type="pmid">16367751</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinaldi</surname><given-names>T.</given-names></name><name><surname>Kulangara</surname><given-names>K.</given-names></name><name><surname>Antoniello</surname><given-names>K.</given-names></name><name><surname>Markram</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>13501</fpage>–<lpage>13506</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0704391104</pub-id><pub-id pub-id-type="pmid">17675408</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinaldi</surname><given-names>T.</given-names></name><name><surname>Perrodin</surname><given-names>C.</given-names></name><name><surname>Markram</surname><given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism.</article-title>
<source/><italic>Front. Neural Circuits</italic>
<volume>2</volume>:<issue>4</issue>
<pub-id pub-id-type="doi">10.3389/neuro.04.004.2008</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodier</surname><given-names>P. M.</given-names></name><name><surname>Ingram</surname><given-names>J. L.</given-names></name><name><surname>Tisdale</surname><given-names>B.</given-names></name><name><surname>Nelson</surname><given-names>S.</given-names></name><name><surname>Romano</surname><given-names>J.</given-names></name></person-group> (<year>1996</year>). <article-title>Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>370</volume>
<fpage>247</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19960624)370:2&lt;247::AID-CNE8&gt;3.0.CO;2-2</pub-id><pub-id pub-id-type="pmid">8808733</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roullet</surname><given-names>F. I.</given-names></name><name><surname>Lai</surname><given-names>J. K.</given-names></name><name><surname>Foster</surname><given-names>J. A.</given-names></name></person-group> (<year>2013</year>). <article-title>In utero exposure to valproic acid and autism–a current review of clinical and animal studies.</article-title>
<source/><italic>Neurotoxicol. Teratol.</italic>
<volume>36</volume>
<fpage>47</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2013.01.004</pub-id><pub-id pub-id-type="pmid">23395807</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>J. L.</given-names></name><name><surname>Merzenich</surname><given-names>M. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Model of autism: increased ratio of excitation/inhibition in key neural systems.</article-title>
<source/><italic>Genes Brain Behav.</italic>
<volume>2</volume>
<fpage>255</fpage>–<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00037.x</pub-id><pub-id pub-id-type="pmid">14606691</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>T.</given-names></name><name><surname>Ziolkowska</surname><given-names>B.</given-names></name><name><surname>Gieryk</surname><given-names>A.</given-names></name><name><surname>Tyminska</surname><given-names>A.</given-names></name><name><surname>Przewlocki</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism.</article-title>
<source/><italic>Psychopharmacology</italic>
<volume>193</volume>
<fpage>547</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-007-0795-y</pub-id><pub-id pub-id-type="pmid">17497229</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwaller</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>The use of transgenic mouse models to reveal the functions of Ca2+ buffer proteins in excitable cells.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1820</volume>
<fpage>1294</fpage>–<lpage>1303</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2011.11.008</pub-id><pub-id pub-id-type="pmid">22138448</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>M. M.</given-names></name><name><surname>Anderson</surname><given-names>A. E.</given-names></name><name><surname>Leung</surname><given-names>V.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Johnston</surname><given-names>D.</given-names></name></person-group> (<year>2004</year>). <article-title>Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons.</article-title>
<source/><italic>Neuron</italic>
<volume>44</volume>
<fpage>495</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.10.011</pub-id><pub-id pub-id-type="pmid">15504329</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohal</surname><given-names>V. S.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Yizhar</surname><given-names>O.</given-names></name><name><surname>Deisseroth</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Parvalbumin neurons and gamma rhythms enhance cortical circuit performance.</article-title>
<source/><italic>Nature</italic>
<volume>459</volume>
<fpage>698</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1038/nature07991</pub-id><pub-id pub-id-type="pmid">19396159</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoner</surname><given-names>R.</given-names></name><name><surname>Chow</surname><given-names>M. L.</given-names></name><name><surname>Boyle</surname><given-names>M. P.</given-names></name><name><surname>Sunkin</surname><given-names>S. M.</given-names></name><name><surname>Mouton</surname><given-names>P. R.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Patches of disorganization in the neocortex of children with autism.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>370</volume>
<fpage>1209</fpage>–<lpage>1219</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1307491</pub-id><pub-id pub-id-type="pmid">24670167</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrigiano</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement.</article-title>
<source/><italic>Annu. Rev. Neurosci.</italic>
<volume>34</volume>
<fpage>89</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-060909-153238</pub-id><pub-id pub-id-type="pmid">21438687</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlhaas</surname><given-names>P. J.</given-names></name><name><surname>Singer</surname><given-names>W.</given-names></name></person-group> (<year>2007</year>). <article-title>What do disturbances in neural synchrony tell us about autism?</article-title>
<source/><italic>Biol. psychiatry</italic>
<volume>62</volume>
<fpage>190</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2007.05.023</pub-id><pub-id pub-id-type="pmid">17631116</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verrotti</surname><given-names>A.</given-names></name><name><surname>Scardapane</surname><given-names>A.</given-names></name><name><surname>Franzoni</surname><given-names>E.</given-names></name><name><surname>Manco</surname><given-names>R.</given-names></name><name><surname>Chiarelli</surname><given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Increased oxidative stress in epileptic children treated with valproic acid.</article-title>
<source/><italic>Epilepsy Res.</italic>
<volume>78</volume>
<fpage>171</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2007.11.005</pub-id><pub-id pub-id-type="pmid">18164182</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinten</surname><given-names>J.</given-names></name><name><surname>Bromley</surname><given-names>R. L.</given-names></name><name><surname>Taylor</surname><given-names>J.</given-names></name><name><surname>Adab</surname><given-names>N.</given-names></name><name><surname>Kini</surname><given-names>U.</given-names></name><name><surname>Baker</surname><given-names>G. A.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>The behavioral consequences of exposure to antiepileptic drugs in utero.</article-title>
<source/><italic>Epilepsy Behav.</italic>
<volume>14</volume>
<fpage>197</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2008.10.011</pub-id><pub-id pub-id-type="pmid">18992367</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vreugdenhil</surname><given-names>M.</given-names></name><name><surname>Jefferys</surname><given-names>J. G.</given-names></name><name><surname>Celio</surname><given-names>M. R.</given-names></name><name><surname>Schwaller</surname><given-names>B.</given-names></name></person-group> (<year>2003</year>). <article-title>Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>89</volume>
<fpage>1414</fpage>–<lpage>1422</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00576.2002</pub-id><pub-id pub-id-type="pmid">12626620</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walcott</surname><given-names>E. C.</given-names></name><name><surname>Higgins</surname><given-names>E. A.</given-names></name><name><surname>Desai</surname><given-names>N. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Synaptic and intrinsic balancing during postnatal development in rat pups exposed to valproic acid in utero.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>13097</fpage>–<lpage>13109</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1341-11.2011</pub-id><pub-id pub-id-type="pmid">21917793</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>M. J.</given-names></name><name><surname>Ostergaard</surname><given-names>K.</given-names></name><name><surname>Andreassen</surname><given-names>O. A.</given-names></name><name><surname>Finsen</surname><given-names>B.</given-names></name></person-group> (<year>1996</year>). <article-title>Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>370</volume>
<fpage>11</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19960617)370:1&lt;11::AID-CNE2&gt;3.3.CO;2-A</pub-id><pub-id pub-id-type="pmid">8797153</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>M. J.</given-names></name><name><surname>Slomianka</surname><given-names>L.</given-names></name><name><surname>Gundersen</surname><given-names>H. J.</given-names></name></person-group> (<year>1991</year>). <article-title>Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator.</article-title>
<source/><italic>Anat. Rec.</italic>
<volume>231</volume>
<fpage>482</fpage>–<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1002/ar.1092310411</pub-id><pub-id pub-id-type="pmid">1793176</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wohr</surname><given-names>M.</given-names></name><name><surname>Orduz</surname><given-names>D.</given-names></name><name><surname>Gregory</surname><given-names>P.</given-names></name><name><surname>Moreno</surname><given-names>H.</given-names></name><name><surname>Khan</surname><given-names>U.</given-names></name><name><surname>Vorckel</surname><given-names>K. J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>5</volume>: <issue>e525</issue>
<pub-id pub-id-type="doi">10.1038/tp.2015.19</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Q.</given-names></name><name><surname>Miao</surname><given-names>Q. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Experience-dependent development of perineuronal nets and chondroitin sulfate proteoglycan receptors in mouse visual cortex.</article-title>
<source/><italic>Matrix Biol.</italic>
<volume>32</volume>
<fpage>352</fpage>–<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2013.04.001</pub-id><pub-id pub-id-type="pmid">23597636</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>F.</given-names></name><name><surname>Danko</surname><given-names>T.</given-names></name><name><surname>Botelho</surname><given-names>S. C.</given-names></name><name><surname>Patzke</surname><given-names>C.</given-names></name><name><surname>Pak</surname><given-names>C.</given-names></name><name><surname>Wernig</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons.</article-title>
<source/><italic>Science</italic>
<volume>352</volume>: <issue>aaf2669</issue>
<pub-id pub-id-type="doi">10.1126/science.aaf2669</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zikopoulos</surname><given-names>B.</given-names></name><name><surname>Barbas</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Altered neural connectivity in excitatory and inhibitory cortical circuits in autism.</article-title>
<source/><italic>Front. Hum. Neurosci.</italic>
<volume>7</volume>:<issue>609</issue>
<pub-id pub-id-type="doi">10.3389/fnhum.2013.00609</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>